The instant disclosure relates generally to percutaneous access and, more specifically, to methods and devices associated with percutaneous access. Generally, the instant disclosure relates to an access port for subcutaneous implantation. In one embodiment, an access port may allow a physician or other medical personnel to obtain long term percutaneous access to the interior of a patient's body. Employing an access port for percutaneous access may reduce the opportunity for infection by inhibiting fluid connections (that extend into the interior of a patient's body) from the patient's skin and from the external environment. The access device allows access to the interior of the patient without requiring a needle to pierce the skin. Further, internal components, such as a catheter or a valve, may be replaced without a surgical procedure. Features or aspects of the instant disclosure may apply to any such access ports for subcutaneous access to a patient, without limitation. The access port may be injected by hand (e.g., via a syringe including a needle) for example, or may be injected and pressurized by mechanical assistance (e.g., a so-called power injectable port).
Power injectable ports may be employed in, among other processes, for example, computed tomography (“CT”) scanning processes. More particularly, a so-called “power injector” system may be employed for injecting contrast media into a peripherally inserted intravenous (IV) line. For example, such power injectors or injection systems may be commercially available from Medrad, Inc., a subsidiary of Schering AG, Germany and may be marketed under the trademark STELLANT®. Because fluid infusion procedures are often defined in terms of a desired flow rate of contrast media, such power injection systems are, in general, controllable by selecting a desired flow rate.
More specifically, the instant disclosure relates to an access port having at least one perceivable or identifiable feature for identifying the access port, wherein the identifiable feature is perceivable after the access port is implanted within a patient. For example, at least one or perhaps multiple identifiable feature(s) of an access port contemplated by the instant disclosure may be correlative to information (e.g., a manufacturer's model or design) pertaining to the access port. Thus, an identifiable feature from an access port of a particular model may be unique in relation to most if not all other identifiable features of another access port of a different models or design. Of course, the at least one identifiable feature of an access port contemplated by the instant disclosure may be further correlative with any information of interest, such as type of port, catheter type, date of manufacture, material lots, part numbers, etc. In one example, at least one identifiable feature of an access port may be correlative with the access port being power injectable. In this way, once at least one identifiable feature of an access port is observed or otherwise determined, correlation of such at least one feature of an access port may be accomplished, and information pertaining to the access port may be obtained.
In one embodiment, at least one feature may be perceived by palpation (i.e., to examine by touch), by way of other physical interaction, or by visual observation. Accordingly, a person of interest may touch or feel the access port through the skin to perceive at least one identifying characteristic thereof. In another embodiment, at least one identifiable feature may be perceived via x-ray or ultrasound imaging. In yet a further embodiment, at least one identifiable feature may be perceived through magnetic, light, or radio energy interaction or communication with the access port.
Turning to the embodiment wherein at least one feature may be perceived through palpation, other physical interaction, or visual observation, a topography or exterior surface feature of an access port contemplated by the instant disclosure may be configured for perception. For example, referring to
The body 20 may be implanted in a patient 7, as shown in
Body 20 of access port 10 may comprise a bio-compatible material such as polysulfone, titanium, acetyl resin, or any other suitably bio-compatible material as known in the art. Accordingly, the body 20 may be formed from a bio-compatible plastic material. If desired, the body 20 may comprise a penetrable material for penetration by sutures or needles. In another embodiment, and as discussed further hereinbelow, body 20 may comprise an impenetrable material such as, for instance, a metal if desired. Body 20 may include a concave bottom or, in another embodiment, may include a flat bottom, without limitation.
According to the instant disclosure, access port 10 may comprise a body 20 exhibiting at least one identifiable feature. More particularly, as shown in
As shown in
It may be appreciated that there are many variations to the geometry of access port 10 as shown in
In another embodiment, in another aspect contemplated by the instant disclosure, a template may be employed for perceiving at least one feature of an access port. For instance, a complementarily-shaped template may be positioned over and abutted against an access port contemplated by the instant disclosure so as to determine if the access port matches or substantially corresponds to the shape of the template. Such a process may reliably indicate or perceive at least one feature of an access port contemplated by the instant disclosure. Of course, a plurality of templates corresponding to different models of access ports may be serially engaged with an unknown access port so as to perceive at least one feature thereof. Such a process may allow for identification (e.g., of a model or manufacturer) of an access port contemplated by the instant disclosure.
In another aspect contemplated by the instant disclosure, an upper topography of an access port may include at least one feature for identifying the access port. For example, as shown in
In yet a further embodiment of an access port contemplated by the instant disclosure, side regions 54 extending between rounded corner regions 30 may exhibit at least one perceivable feature. For example, as shown in
In a further embodiment of an access port contemplated by the instant disclosure,
Of course, one or more side surfaces of an access port according to the instant disclosure may be configured for forming a body exhibiting a selected shape as may be desired. An elongated body portion of an access port contemplated by the instant disclosure may form, in combination with other features as described hereinabove or, in another embodiment, taken alone, at least one perceivable feature for identification of an access port according to the instant disclosure.
It should be understood that the instant disclosure contemplates access ports having an exterior geometry that is not quadrilateral in nature. Rather, the instant disclosure contemplates that an access port may have an exterior which is generally cylindrical, generally conical, generally elliptical, generally oval, or an exterior that is otherwise arcuate in nature. Specifically, the instant disclosure contemplates that an access port having a substantially rounded or arcuate exterior may include at least one feature configured for identification of the access port after implantation. For example, as shown in
The instant disclosure further contemplates that at least one protrusion, protruding region, recess, recessed region, undulation, or adjacent features of different elevation may comprise a feature for identifying an access port contemplated by the instant disclosure. More specifically, upper topography 61C, as shown in
Further,
In a further embodiment of an access port contemplated by the instant disclosure,
In a further embodiment of an access port contemplated by the instant disclosure,
In a further embodiment of an access port contemplated by the instant disclosure,
In a further embodiment of an access port contemplated by the instant disclosure,
In a further embodiment of an access port contemplated by the instant disclosure,
It should be understood from the above-described various embodiments of an access port contemplated by the instant disclosure that many variations, additions, or different features may be encompassed by the instant disclosure. Thus, the instant disclosure is not limited to the several above-described exemplary embodiments.
For example, as shown in
Additionally, the instant disclosure contemplates access ports having an exterior geometry that is polygonal in nature. Specifically, the instant disclosure contemplates that an access port contemplated by the instant disclosure may exhibit a generally triangular exterior. Thus, as shown in
Additionally,
The instant disclosure also contemplates that at least one feature of an access port contemplated by the instant disclosure may not be observable visually or by palpation but, rather, may be otherwise observable. For example, the instant disclosure contemplates that at least one feature of an access port may be observable through interaction with an imaging technology such as x-ray or ultrasound. For example, in one embodiment, a metal feature (e.g., a plate or other metal geometry) may be included by an access port contemplated by the instant disclosure. As may be appreciated, such a metal feature may be represented on an x-ray generated by exposure of the access port to x-ray energy while simultaneously exposing x-ray sensitive film to x-ray energy passing through the access port. Further, the instant disclosure contemplates that a size, shape, or both size and shape of a metal feature of an access port may be configured for enhancing identification of an access port. For example, assuming that a metal feature comprises a metal plate, a size, shape, or both may be selectively tailored for identification of an access port. Similarly, a feature of an access port contemplated by the instant disclosure may be tailored for detection via ultrasound interaction. Such a feature may comprise an exterior topographical feature. In another embodiment, such a feature may comprise a composite structure including two or more materials that form an interface surface that may be identified by ultrasound imaging.
One example embodiment of a feature observable through interaction with imaging technology contemplated by the instant disclosure is shown in
As mentioned above,
Although also useful in access ports where only a portion of a port includes a metallic material, e.g., a metal plate, the engraving technique is well-suited in one embodiment for access ports that are composed of solid metal, such as titanium, stainless steel, or other materials that are typically radiopaque, i.e., non-transmissive to x-rays in sufficient thickness.
Regardless of the cut profile used, better contrast is achieved generally with greater engraving depth X. The optimal engraving depth X will depend, however, on the thickness of the overall cavity base 220, which is the portion of the base directly below the cavity 36, as shown in
It is also contemplated by this disclosure that the use of an identification feature in a metallic or other radiopaque access port can be applied to access ports having a variety of possible configurations, such as is seen in
In another embodiment contemplated by the instant disclosure,
Additionally, the instant disclosure contemplates access ports having any variety or combination of desired identification features for indicating power-injectability or other aspect or characteristic of an access port. Specifically,
In additional embodiments, the identification feature can be defined on an inside bottom surface 36B of the cavity 36 of an access port 10, or in addition to the identification feature 200 provided on the bottom surface 251. In another embodiment, the material surrounding the defining edges of the desired radiopaque alphanumeric character, symbol, pattern, etc., can be removed instead of removing the desired feature shape itself so as to define a “positive” relief image of the identification feature. Such a positive relief identification feature can be defined on a lower surface of an access port body or on the inside bottom surface of the cavity, for example.
In addition to the various types of symbols, patterns, marks, and alphanumeric characters that are contemplated by the instant disclosure,
In a further aspect contemplated by the instant disclosure, it is contemplated that a communicative technology may be utilized wherein information is encompassed by an access port contemplated by the instant disclosure. Generally, a communication device (e.g., a radio beacon, a light-emitting element, an ultrasound emitting transducer, etc.), may be imbedded or otherwise affixed to an access port contemplated by the instant disclosure. Such a communication device may be configured for transmitting information in response to a given impetus. More specifically, the instant disclosure contemplates that an access port contemplated by the instant disclosure may be exposed to a request signal (e.g., a sound, an impact or an acceleration, light, radio waves, etc.). Such a request signal may cause the communication device to transmit information therefrom via sound, light, radio waves, or as otherwise known in the art. Such information may be employed for identifying an access port contemplated by the instant disclosure.
In one exemplary example, it is contemplated that radio frequency identification technology may be employed for identification of an access port contemplated by the instant disclosure. Particularly, so-called active RFID tags are powered by an internal battery and are typically read/write devices. Currently, a suitable cell coupled to suitable low power circuitry can ensure functionality for as long as ten or more years, depending upon the operating temperatures and read/write cycles and usage. So-called passive RFID tags operate without a separate external power source and obtain operating power generated from the reader. Passive RFID tags are typically programmed with a unique set of data (usually 32 to 128 bits) that cannot be modified. Read-only tags may operate as an identifier comparable to linear barcodes which may contain selected product-specific information. Thus, passive RFID tags may be much lighter than active RFID tags, less expensive, and may offer a virtually unlimited operational lifetime. The tradeoff is that they have shorter read ranges than active tags and require a higher-powered reader.
One advantage of RFID approach is the noncontact, non-line-of-sight nature of the technology. Tags can be read through a variety of substances such as snow, fog, ice, paint, crusted grime, and other visually and environmentally challenging conditions, where other optically read technologies may be less effective. RFID tags can also be read in challenging circumstances at rapid speeds, in most cases responding in less than about 100 milliseconds.
Reference is now generally made to
In the present embodiment the retaining ring 330 includes an identification feature 200 for identifying a predetermined attribute or characteristic of the port 310 after implantation thereof. Specifically, the retaining ring 330 includes alphanumeric character identification features 200A spelling “POWER INJECTABLE,” which indicates that the port 310 is capable of power injection. The alphanumeric characters in one embodiment are inset via etching or otherwise suitably defined in the retaining ring 330 so as to provide a relative thickness difference between the characters and surrounding metallic retaining ring material, thus providing a corresponding radiographic contrast when the port 310 is imaged with x-ray imaging technology. This contrast enables the alphanumeric characters to become visible in an x-ray and therefore discernible by a clinician viewing the x-ray, thus enabling the port attribute or characteristic relating to the identification feature 200 to be ascertained.
Note that the alphanumeric identification features 200A can be defined on the retaining ring 330 in any number of suitable ways, including etching, engraving, etc., and the characters can be defined partially or completely through the retaining ring. Also, the particular characters or words used can vary from what is described here. Indeed, other characters, patterns, symbols, etc. can be employed in the identification feature 200. Optionally, the identification features can be defined in negative relief, as shown in
Additionally, in other embodiments the identification feature of the retaining ring can be configured in other ways according to the configuration of the port. For instance, in embodiments where the port body includes a non-metallic material, the identification feature can include radiopaque ink that is applied to a surface of the retaining ring so as to form the alphanumeric or other characters or features. In yet other embodiments, the identification feature can be included on portions or surfaces of the port in addition to the retaining ring. These and other modifications are therefore contemplated.
The radiopaque marking of the identification feature 200 can include a metallic powder intermixed with an ink-based marking. Specifically, in one embodiment, the radiopaque marking includes tungsten powder intermixed with 1020 black wire marking ink manufactured by Gem Gravure, Inc. of West Hanover, Mass., in a ratio of three parts tungsten powder to one part ink. Mixing of the two components can include ball mixing to ensure good component integration in one embodiment. Also, additives can be added to the mixture to attain a proper mixture viscosity.
In other embodiments, the powder-to-ink ratio can be modified from that described above, including 2:1, 4:1, and 5:1 ratios, for instance. The ideal ratio will vary according to the type of materials employed in the mixture, the density of the desired image, powder particle size, amount of mixture applied to the port, etc. In yet other embodiments, other medical grade inks or suitable liquids, as well as other biocompatible metallic powders or suitable radiopaque materials, could be used. In one embodiment, a ceramic, such as zirconium oxide powder, can be intermixed with a marking ink to provide the radiopaque marking. Ink thinners can also be added to the mixture, along with other suitable substances as appreciated by those skilled in the art.
As shown in
The substrate 440 is employed as a base on which the radiopaque marking can be deposited in preparation for integration of the substrate and marking into the port 410 during an injection molding process so as to encapsulate the radiopaque marking within the molded port. In detail, in one embodiment, the radiopaque marking, including the above-described ink/powder mixture or other suitable substance, is first deposited on a surface of the substrate 440 via any acceptable process, including pad printing, manual or automatic painting, silk screening, use of a template, etc. To improve adhesion of the ink/powder mixture, the substrate can be plasma treated or corona treated in one embodiment.
Once the radiopaque marking has been applied to the substrate 440, the substrate is loaded into a mold, such as that shown in
The port 410 is then fabricated by an injection molding process. The substrate 440 is thus insert-molded into the port 410 via the injection molding process, which bonds the substrate 440 to the molded body of the port 410, thus encapsulating the radiopaque marking of the identification feature 200 within the port and preventing its inadvertent removal. Additionally, due to the relative thinness of the substrate 440, the identification feature remains visible through the substrate from outside of the port 410, as seen in
It is appreciated that in other embodiments, the substrate can be configured to be positioned in other regions of the port. In yet other embodiments, other substrate materials can be used. For instance, in one embodiment the substrate can include woven high-density polyethylene sold under the brand TYVEK®. In this case, the substrate 440 does not permanently adhere to the port 410 as a result of the insert molding process, but is removed after molding process is complete. The radiopaque marking ink/powder mixture initially included on the woven substrate 440, however, is integrated into the port body and remains with the port 410 after molding and substrate removal to serve as the identification feature 200. Flaps or flanges can be included on the substrate to facilitate its separation from the substrate from the port after molding, in one embodiment. In another embodiment, the ink/powder radiopaque marker mixture is allowed to dry on the substrate 440 after application thereon to improve adhesion to the port 410 during the insert molding process. In addition to those explicitly described here, other suitable materials can be used as the substrate. In yet another embodiment, no substrate is used and the ink/powder radiopaque marker mixture is applied directly to the mold surface before the port 410 is molded therein.
The substrate 440 with the included identification feature 200 can then be inserted into a mold and insert-molded to form part of a base 616 of an access port. The radiopaque identification feature 200, now encapsulated within the base, provides the desired identification of a predetermined attribute or characteristic of the port once manufacture of the port is complete.
Reference is now made to
In one embodiment, the fill material 448 is injected into the cavity 446 by a pressurized syringe, such as an electronic fluid dispenser, though other suitable techniques can also be employed, including manual filling by syringe. Any excess fill material 448 can be removed from the port base bottom surface 416A after filling, and the fill material can be allowed to cure. Note that in other embodiments the bottom surface of the port can include other portions of the port in addition or instead of the base, as shown in
In the present embodiment, the radiopaque annular portion 470 includes barium sulfate-loaded silicone, while the remainder of the septum 468 is unloaded silicone. In other embodiments, other suitable radiopaque materials can be employed with silicone or other septum materials. In one embodiment, the septum 468 of
In another embodiment, the present septum 468 is manufactured integrally via a co-molding process, wherein separate injection heads are employed in a mold cavity in order to injection mold the annular portion 470 with one or more heads and the rest of the septum 468 with separate heads. These and other manufacturing methods are therefore considered within the spirit of the present disclosure.
The principles discussed in connection with
In one embodiment, the septum, suture plugs, or other portion of the port can include an ultraviolet light-sensitive material. The ultraviolet light-sensitive material can be applied to the surface of the port component or can impregnated into the component. After implantation of the port, ultraviolet light is directed through the skin of the patient to be incident on the ultraviolet light-sensitive material of the port, which causes the material to fluoresce with visible light that is observable through the skin of the patient, thus identifying the port and/or its predetermined attribute or characteristic.
It is appreciated that a radiopaque identification feature can be included or associated with a port in other ways in addition to those embodiments already described. Examples of this can be found in the embodiments depicted in
In
In
As shown in
Reference is now generally made to
In particular,
Alphanumeric indicia 200A are also included on a lower portion of the insert 750, though it is appreciated that such indicia can vary in positional placement, size, type, etc. The indicia 200A of the identification feature 200 in the present embodiment include the letters “C” and “T” and indicate an attribute of the access port in which the insert is included, such as the access port 510 shown in
In detail,
As already indicated, the indicia 200A of the identification feature 200 in the present embodiment include the “C” and “T” letter-shaped holes that are defined through the insert 750 and indicate a predetermined attribute of the access port 510. In the present embodiment, the identification feature 200 and the alphanumeric indicia 200A indicate that the access port 510 is capable of power injection. Of course, other attributes of the access port can be designated by the identification feature, if desired.
The insert 750 is configured to be radiopaque so as to provide the identification feature 200 when the access port 510 or other suitable medical device that is not sufficiently radiopaque is imaged under x-ray. Examples of access ports not sufficiently radiopaque to be suitably imaged include those including a thermoplastic, such as acetyl resin for instance. When so imaged, the insert 750 of the access port 510 is visible in the radiographic image and will therefore provide desired identification to a clinician viewing the x-ray image of the predetermined port attribute relating to the identification feature 200. In particular, the radiopacity of the insert 750 itself provides a contrast to the radiotranslucent “C” and “T” alphanumeric indicia 200A and other features that are defined through the insert, thus enabling those features to be readily identified in an x-ray image.
It is appreciated that the particular items employed in the identification feature and indicia can vary from what is described here. Indeed, a variety of characters, symbols, patterns, words, etc. can be employed. Optionally, the identification features can be defined in negative or positive relief, as desired. Further, it is appreciated that the geometric holes and indicia described above in connection with the identification feature 200 of the insert 750 can define together or separately one or more attributes of the access port 510 or other implantable device including the insert, as may be appreciated by one skilled in the art. Of course, the shape of the insert itself can also vary from what is shown here.
In the present embodiment, the insert 750 is composed of a mixture including acetyl resin and bismuth trioxide. In one embodiment, for instance, the insert 750 is composed of a mixture including about 70 percent by weight acetyl resin, e.g., polyoxymethylene (“POM”), sold under the brand DELRIN® and about 30 percent bismuth trioxide by weight. Other relatively differing concentrations of these two materials can also be used, depending on the desired radiopacity of the insert and other factors. For instance, relatively smaller or greater concentrations of bismuth trioxide may be employed, including 10, 20, 50 percent, etc. Likewise, though in the present embodiment the insert thickness is approximately 0.020 inch, other insert thicknesses could be used. Further, as mentioned the shape, size, and design of the insert can vary from what is shown in the accompanying drawings. The bismuth trioxide in one embodiment is added to the acetyl resin in powder form to define the mixture before molding, though other forms of bismuth trioxide or other suitable radiopaque material can also be employed.
The insert 750 is formed in one embodiment by injection molding, though in other embodiments other processes, including machining and other molding procedures, may be used. For instance, in one embodiment, the insert is formed by first extruding a length of extruded material, then slicing the extrusion into individual inserts. In another embodiment, the insert is provided by stamping or cutting the insert from a formed sheet of material including the base and radiopaque materials. These and other procedures are therefore contemplated.
Once formed, the insert 750 can be included in the access port 510 during manufacture of the access port. In one embodiment, inclusion of the insert 750 in the access port 510 is achieved via an insert-molding process, wherein the already-formed insert is placed into the access port mold, then the access port or a portion thereof is injection molded about the insert to ultimately produce a port appearing similar to that shown in
Note that in other embodiments other processes can be used to mate the insert to the access port, including placement of the insert in a pre-defined recess of the access port, for instance. In the latter case, the insert could be ultrasonically welded into place within the recess, or by some other suitable attachment process.
Note that the access port 510 shown here includes both a cap 514 and the base 516, though in other embodiments, single piece or other types of multi-part ports can benefit from the principles described herein.
With the insert 750 positioned as shown in
Note that, because bismuth trioxide is not a metal, but rather a metal oxide, a non-metallic access port including an insert partially formed from bismuth trioxide can be used without difficulty in situations where the presence of metal is problematic, such as in magnetic resonance imaging (M.R.I.). Further, in the present embodiment the base material of the insert (acetyl resin) is substantially similar to the material from which the access port body is manufactured (also acetyl resin). As such, both include similar coefficients of expansion and contraction. This prevents warping of the insert as the insert and surrounding port body material cool after the insert molding process is complete. Also, because the insert includes a relatively soft base material, the mold will not be damaged if the insert is somehow malpositioned during the insertion molding process.
As mentioned, other materials can be employed in manufacturing the radiopaque insert 750 and other inserts described herein, including a suitable biocompatible base material in place of the acetyl resin and a suitable biocompatible radiopaque material in place of the bismuth trioxide. One suitable combination for forming the insert includes a base material of polycarbonate sold under the name MAKROLON® 2558 and tungsten as the radiopaque material. Other suitable base materials include biocompatible thermoplastic materials. Other possible radiopaque materials include precious metals including gold, silver, etc., barium sulfate and other suitable sulfates, suitable oxides, and suitably dense ceramics including alumina, zirconia, etc. Such materials are therefore contemplated.
In one embodiment, it is appreciated that the use of a base material that is the same material employed for forming the access port body enables the insert to shrink at a similar rate to that of the port body during the molding process, thus desirably preventing warping of the of the port body or insert.
As mentioned, the insert including the identification feature can include other configurations, one example of which is shown in
Also as before, the composition of the insert 800 includes a mixture of acetyl resin and bismuth trioxide in relative concentrations similar to those of the previous embodiment so as to render the insert radiopaque when included in an access port or other implantable device and is radiographically imaged using x-ray imaging technology. Again, many different character, pattern, and/or combination configurations are possible. For instance, in addition to identifying the access port as power injectable, this and other identification features described herein can be used to designate lot numbers, hospital identification, port brand, etc.
Reference is now generally made to
Using silk screen printing methods, the identification feature in the form of a pattern, symbol, indicia, and/or alphanumeric character(s) is deposited onto a surface of the access port. For example, in one embodiment, the screen 902 is brought into contact with the surface to be marked, which in the embodiment of
As noted above, although the surface onto which the radiopaque material is deposited in
The silk screening process to deposit a radiopaque identification feature on a surface of an access port can utilize surface energy enhancement methods for adhering the radiopaque mixture/suspension. For example, the surface on which the radiopaque mixture/suspension is to be deposited could first be activated via a plasma modification technique, such as a Corona Treatment. It is noted that the silk screening process described herein is applicable to any material surface of an access port, including but not limited to plastic, silicone, metal, and combinations thereof.
It is appreciated that a radiopaque identification feature in accordance with the principles described herein can be employed in other applications. For instance, in one embodiment, a radiopaque identification feature including a suitable base material and bismuth trioxide or other suitable radiopaque material described herein can be employed as a distal end plug for a lumen of a catheter. These and other possible applications are therefore contemplated.
While certain representative embodiments and details have been shown for purposes of illustrating aspects contemplated by the instant disclosure, it will be apparent to those skilled in the art that various changes in the methods and apparatus disclosed herein may be made without departing form the scope contemplated by the instant disclosure, which is defined in the appended claims. For example, other access port sizes and shapes may be employed; and various other embodiments and structures may be employed for forming at least one identifiable feature of an access port contemplated by the instant disclosure. In particular, the access port may be formed in any number of shapes and sizes, such that any number of modifications and changes are possible to any of the embodiments described and illustrated herein without departing from the spirit and scope of the instant disclosure.
This application is a continuation of U.S. patent application Ser. No. 15/881,616, filed Jan. 26, 2018, now U.S. Pat. No. 10,179,230, which is a division of U.S. patent application Ser. No. 14/599,376, filed Jan. 16, 2015, now U.S. Pat. No. 10,238,850, which is a division of U.S. patent application Ser. No. 13/776,517, filed Feb. 25, 2013, now U.S. Pat. No. 8,939,947, which is a division of U.S. patent application Ser. No. 13/250,909, filed Sep. 30, 2011, now U.S. Pat. No. 8,382,724, which is a division of U.S. patent application Ser. No. 12/796,133, filed Jun. 8, 2010, now U.S. Pat. No. 8,029,482, which is a continuation-in-part of U.S. patent application Ser. No. 12/610,084, filed Oct. 30, 2009, now U.S. Pat. No. 8,202,259, which claims the benefit of U.S. Patent Application No. 61/110,507, filed Oct. 31, 2008, and which is a continuation-in-part of U.S. patent application Ser. No. 12/420,028, filed Apr. 7, 2009, now U.S. Pat. No. 7,947,022, which is a continuation-in-part of the U.S. patent application Ser. No. 11/368,954, filed Mar. 6, 2006, now U.S. Pat. No. 7,785,302, which claims the benefit of U.S. Patent Application No. 60/658,518, filed Mar. 4, 2005, each of which applications is incorporated, in its entirety, by this reference.
Number | Name | Date | Kind |
---|---|---|---|
445896 | Kinsman | Feb 1891 | A |
546440 | Tufts | Sep 1895 | A |
574387 | Buckler | Jan 1897 | A |
611357 | Dembinski | Sep 1898 | A |
966696 | Merrill | Aug 1910 | A |
D44302 | Director | Jul 1913 | S |
1713267 | Crowley | May 1929 | A |
D130852 | Rothschild | Dec 1941 | S |
2433480 | Rendich | Dec 1947 | A |
2891689 | Gould | Jun 1959 | A |
3159175 | Macmillan | Dec 1964 | A |
3211431 | Meysembourg et al. | Oct 1965 | A |
3293663 | Cronin | Dec 1966 | A |
3341417 | Sinaiko | Sep 1967 | A |
3477438 | Allen et al. | Nov 1969 | A |
3518428 | Ring | Jun 1970 | A |
3525357 | Koreski | Aug 1970 | A |
3529633 | Vaillancourt | Sep 1970 | A |
3540670 | Rissberger | Nov 1970 | A |
3643358 | Morderosian | Feb 1972 | A |
3669323 | Harker et al. | Jun 1972 | A |
3674183 | Venable et al. | Jul 1972 | A |
3811466 | Ohringer | May 1974 | A |
3829904 | Ling et al. | Aug 1974 | A |
3831549 | Parsons | Aug 1974 | A |
3831583 | Edmunds, Jr. et al. | Aug 1974 | A |
3840009 | Michaels et al. | Oct 1974 | A |
3853127 | Spademan | Dec 1974 | A |
3891997 | Herbert | Jul 1975 | A |
3915162 | Miller | Oct 1975 | A |
3919724 | Sanders et al. | Nov 1975 | A |
3922726 | Trentani et al. | Dec 1975 | A |
3951147 | Tucker et al. | Apr 1976 | A |
3955594 | Snow | May 1976 | A |
3971376 | Wichterle | Jul 1976 | A |
4013064 | Patel et al. | Mar 1977 | A |
4027391 | Samis | Jun 1977 | A |
4035653 | Karasko | Jul 1977 | A |
4121108 | Manor | Oct 1978 | A |
4123806 | Amstutz et al. | Nov 1978 | A |
4143853 | Abramson | Mar 1979 | A |
4168586 | Samis | Sep 1979 | A |
4181132 | Parks | Jan 1980 | A |
4190040 | Schulte | Feb 1980 | A |
4190057 | Hill et al. | Feb 1980 | A |
4194122 | Mitchell et al. | Mar 1980 | A |
4196731 | Laurin et al. | Apr 1980 | A |
4202349 | Jones | May 1980 | A |
4222374 | Sampson et al. | Sep 1980 | A |
4233964 | Jefferts et al. | Nov 1980 | A |
4274006 | Caine | Jun 1981 | A |
4286597 | Gajewski et al. | Sep 1981 | A |
D263335 | Bujan | Mar 1982 | S |
4349498 | Ellis et al. | Sep 1982 | A |
4361153 | Slocum et al. | Nov 1982 | A |
4405305 | Stephen et al. | Sep 1983 | A |
4406567 | Samis | Sep 1983 | A |
4425119 | Berglund | Jan 1984 | A |
4445896 | Gianturco | May 1984 | A |
4447237 | Frisch et al. | May 1984 | A |
4450592 | Niederer et al. | May 1984 | A |
4450985 | Beard | May 1984 | A |
4456011 | Warnecke | Jun 1984 | A |
4469483 | Becker et al. | Sep 1984 | A |
4479798 | Parks | Oct 1984 | A |
4494545 | Slocum et al. | Jan 1985 | A |
4506676 | Duska | Mar 1985 | A |
4529635 | Sheldon | Jul 1985 | A |
4543088 | Bootman et al. | Sep 1985 | A |
4549879 | Groshong et al. | Oct 1985 | A |
4559043 | Whitehouse et al. | Dec 1985 | A |
4559046 | Groshong et al. | Dec 1985 | A |
4560375 | Schulte et al. | Dec 1985 | A |
4569675 | Prosl et al. | Feb 1986 | A |
4571749 | Fischell | Feb 1986 | A |
4576595 | Aas et al. | Mar 1986 | A |
4610665 | Matsumoto et al. | Sep 1986 | A |
4612877 | Hayes et al. | Sep 1986 | A |
4626244 | Reinicke | Dec 1986 | A |
4627844 | Schmitt | Dec 1986 | A |
4634427 | Hannula et al. | Jan 1987 | A |
4636194 | Schulte et al. | Jan 1987 | A |
4636213 | Pakiam | Jan 1987 | A |
4645495 | Vaillancourt | Feb 1987 | A |
4653508 | Cosman | Mar 1987 | A |
4655765 | Swift | Apr 1987 | A |
4657024 | Coneys | Apr 1987 | A |
4662652 | Hargis | May 1987 | A |
4668221 | Luther | May 1987 | A |
4671796 | Groshong et al. | Jun 1987 | A |
4673394 | Fenton, Jr. et al. | Jun 1987 | A |
4681560 | Schulte et al. | Jul 1987 | A |
4684365 | Reinicke | Aug 1987 | A |
4685447 | Iversen et al. | Aug 1987 | A |
4685905 | Jeanneret nee Aab | Aug 1987 | A |
4692146 | Hilger | Sep 1987 | A |
4695273 | Brown | Sep 1987 | A |
4697595 | Breyer et al. | Oct 1987 | A |
4701166 | Groshong et al. | Oct 1987 | A |
4704103 | Stober et al. | Nov 1987 | A |
4707389 | Ward | Nov 1987 | A |
4710167 | Lazorthes | Dec 1987 | A |
4710174 | Moden et al. | Dec 1987 | A |
4718894 | Lazorthes | Jan 1988 | A |
4723947 | Konopka | Feb 1988 | A |
4728894 | Yoda et al. | Mar 1988 | A |
4743231 | Kay et al. | May 1988 | A |
4753640 | Nichols et al. | Jun 1988 | A |
4755173 | Konopka et al. | Jul 1988 | A |
4760837 | Petit | Aug 1988 | A |
4762517 | McIntyre et al. | Aug 1988 | A |
4767410 | Moden et al. | Aug 1988 | A |
4772270 | Wiita et al. | Sep 1988 | A |
4772276 | Wiita et al. | Sep 1988 | A |
4773552 | Boege et al. | Sep 1988 | A |
4778452 | Moden et al. | Oct 1988 | A |
4781680 | Redmond et al. | Nov 1988 | A |
4781685 | Lehmann et al. | Nov 1988 | A |
4781695 | Dalton | Nov 1988 | A |
4784646 | Feingold | Nov 1988 | A |
4793635 | Lovison | Dec 1988 | A |
4802885 | Weeks et al. | Feb 1989 | A |
4804054 | Howson et al. | Feb 1989 | A |
4820273 | Reinicke | Apr 1989 | A |
4822341 | Colone | Apr 1989 | A |
4840615 | Hancock et al. | Jun 1989 | A |
4848346 | Crawford | Jul 1989 | A |
4857053 | Dalton | Aug 1989 | A |
4861341 | Woodburn | Aug 1989 | A |
4863470 | Carter | Sep 1989 | A |
4886501 | Johnston et al. | Dec 1989 | A |
4886502 | Poirier et al. | Dec 1989 | A |
4892518 | Cupp et al. | Jan 1990 | A |
4895561 | Mahurkar | Jan 1990 | A |
4897081 | Poirier et al. | Jan 1990 | A |
4904241 | Bark | Feb 1990 | A |
4905709 | Bieganski et al. | Mar 1990 | A |
4908029 | Bark et al. | Mar 1990 | A |
4909250 | Smith | Mar 1990 | A |
4915690 | Cone et al. | Apr 1990 | A |
4928298 | Tanaka | May 1990 | A |
4929236 | Sampson | May 1990 | A |
4955861 | Enegren et al. | Sep 1990 | A |
4961267 | Herzog | Oct 1990 | A |
4963133 | Whipple | Oct 1990 | A |
4966583 | Debbas | Oct 1990 | A |
4973319 | Melsky | Nov 1990 | A |
4983162 | Metais et al. | Jan 1991 | A |
5002735 | Alberhasky et al. | Mar 1991 | A |
5006115 | McDonald | Apr 1991 | A |
5009391 | Steigerwald | Apr 1991 | A |
5009644 | McDonald | Apr 1991 | A |
5013298 | Moden et al. | May 1991 | A |
5041098 | Loiterman et al. | Aug 1991 | A |
5044955 | Jagmin | Sep 1991 | A |
5045060 | Melsky et al. | Sep 1991 | A |
5045064 | Idriss | Sep 1991 | A |
5053013 | Ensminger et al. | Oct 1991 | A |
5059186 | Yamamoto et al. | Oct 1991 | A |
5069206 | Crosbie | Dec 1991 | A |
5084015 | Moriuchi | Jan 1992 | A |
5085216 | Henley, Jr. et al. | Feb 1992 | A |
5090066 | Schoepe et al. | Feb 1992 | A |
5092849 | Sampson | Mar 1992 | A |
5108317 | Beinhaur et al. | Apr 1992 | A |
5108375 | Harrison et al. | Apr 1992 | A |
5108377 | Cone et al. | Apr 1992 | A |
5112301 | Fenton, Jr. et al. | May 1992 | A |
5112303 | Pudenz et al. | May 1992 | A |
5129891 | Young | Jul 1992 | A |
5137529 | Watson et al. | Aug 1992 | A |
5147483 | Melsky et al. | Sep 1992 | A |
5152753 | Laguette et al. | Oct 1992 | A |
5156600 | Young | Oct 1992 | A |
5158547 | Doan et al. | Oct 1992 | A |
5167629 | Vertenstein et al. | Dec 1992 | A |
5167633 | Mann et al. | Dec 1992 | A |
5167638 | Felix et al. | Dec 1992 | A |
5169393 | Moorehead et al. | Dec 1992 | A |
5171228 | McDonald | Dec 1992 | A |
5176653 | Metals | Jan 1993 | A |
5176662 | Bartholomew et al. | Jan 1993 | A |
5178612 | Fenton, Jr. | Jan 1993 | A |
5180365 | Ensminger et al. | Jan 1993 | A |
5185003 | Brethauer | Feb 1993 | A |
5189690 | Samuel | Feb 1993 | A |
5193106 | DeSena | Mar 1993 | A |
5195122 | Fabian | Mar 1993 | A |
5195123 | Clement | Mar 1993 | A |
5201715 | Masters | Apr 1993 | A |
5201722 | Moorehead et al. | Apr 1993 | A |
5203771 | Melker et al. | Apr 1993 | A |
5203777 | Lee | Apr 1993 | A |
5205834 | Moorehead et al. | Apr 1993 | A |
5207644 | Strecker | May 1993 | A |
5213574 | Tucker | May 1993 | A |
5215537 | Lynn et al. | Jun 1993 | A |
5222499 | Allen et al. | Jun 1993 | A |
5222982 | Ommaya | Jun 1993 | A |
D337637 | Tucker | Jul 1993 | S |
5224938 | Fenton, Jr. | Jul 1993 | A |
5242415 | Kantrowitz et al. | Sep 1993 | A |
5246462 | Bekki et al. | Sep 1993 | A |
5249598 | Schmidt | Oct 1993 | A |
5263930 | Ensminger | Nov 1993 | A |
D342134 | Mongeon | Dec 1993 | S |
5281199 | Ensminger et al. | Jan 1994 | A |
5281205 | McPherson | Jan 1994 | A |
5290263 | Wigness et al. | Mar 1994 | A |
5295658 | Atkinson et al. | Mar 1994 | A |
5299253 | Wessels | Mar 1994 | A |
5300048 | Drewes, Jr. et al. | Apr 1994 | A |
5309863 | Leeb, Jr. | May 1994 | A |
5312337 | Flaherty et al. | May 1994 | A |
5318545 | Tucker | Jun 1994 | A |
5320100 | Herweck et al. | Jun 1994 | A |
5328480 | Melker et al. | Jul 1994 | A |
5332398 | Miller et al. | Jul 1994 | A |
5336194 | Polaschegg et al. | Aug 1994 | A |
5338398 | Szwejkowski et al. | Aug 1994 | A |
5350360 | Ensminger et al. | Sep 1994 | A |
5352204 | Ensminger | Oct 1994 | A |
5356381 | Ensminger et al. | Oct 1994 | A |
5360407 | Leonard et al. | Nov 1994 | A |
5383223 | Inokuchi | Jan 1995 | A |
5383233 | Russell | Jan 1995 | A |
5383585 | Weiss | Jan 1995 | A |
5383858 | Reilly et al. | Jan 1995 | A |
D355240 | Gladfelter et al. | Feb 1995 | S |
5387192 | Glantz et al. | Feb 1995 | A |
5394457 | Leibinger et al. | Feb 1995 | A |
5395324 | Hinrichs et al. | Mar 1995 | A |
5396925 | Poli | Mar 1995 | A |
5397329 | Allen | Mar 1995 | A |
5399168 | Wadsworth, Jr. et al. | Mar 1995 | A |
5405402 | Dye et al. | Apr 1995 | A |
5417565 | Long | May 1995 | A |
5417656 | Ensminger et al. | May 1995 | A |
5421814 | Geary | Jun 1995 | A |
5423334 | Jordan | Jun 1995 | A |
5425762 | Muller | Jun 1995 | A |
5453097 | Paradis | Sep 1995 | A |
5456698 | Byland et al. | Oct 1995 | A |
5476451 | Ensminger et al. | Dec 1995 | A |
5476460 | Montalvo | Dec 1995 | A |
5476880 | Cooke et al. | Dec 1995 | A |
5484402 | Saravia et al. | Jan 1996 | A |
5503630 | Ensminger et al. | Apr 1996 | A |
5507813 | Dowd et al. | Apr 1996 | A |
5509805 | Jagmin | Apr 1996 | A |
5513637 | Twiss et al. | May 1996 | A |
5514103 | Srisathapat et al. | May 1996 | A |
5520632 | Leveen et al. | May 1996 | A |
5520643 | Ensminger et al. | May 1996 | A |
5527277 | Ensminger et al. | Jun 1996 | A |
5527278 | Ensminger et al. | Jun 1996 | A |
5527307 | Srisathapat et al. | Jun 1996 | A |
5531684 | Ensminger et al. | Jul 1996 | A |
5542923 | Ensminger et al. | Aug 1996 | A |
5545143 | Fischell | Aug 1996 | A |
5554117 | Ensminger et al. | Sep 1996 | A |
5556381 | Ensminger et al. | Sep 1996 | A |
5558641 | Glantz et al. | Sep 1996 | A |
5558829 | Petrick | Sep 1996 | A |
5562617 | Finch, Jr. et al. | Oct 1996 | A |
5562618 | Cai et al. | Oct 1996 | A |
5575770 | Melsky et al. | Nov 1996 | A |
5593028 | Haber et al. | Jan 1997 | A |
5593434 | Williams | Jan 1997 | A |
5607393 | Ensminger et al. | Mar 1997 | A |
5607407 | Tolkoff et al. | Mar 1997 | A |
5613945 | Cai et al. | Mar 1997 | A |
5620419 | Lui et al. | Apr 1997 | A |
5632729 | Cai et al. | May 1997 | A |
5637102 | Tolkoff et al. | Jun 1997 | A |
5638832 | Singer et al. | Jun 1997 | A |
5647855 | Trooskin | Jul 1997 | A |
RE35601 | Eckenhoff | Sep 1997 | E |
5662600 | Watson et al. | Sep 1997 | A |
5662612 | Niehoff | Sep 1997 | A |
5662616 | Bousquet | Sep 1997 | A |
5676146 | Scarborough | Oct 1997 | A |
5695490 | Flaherty et al. | Dec 1997 | A |
5702128 | Maxim et al. | Dec 1997 | A |
5702363 | Flaherty | Dec 1997 | A |
5704915 | Melsky et al. | Jan 1998 | A |
5707357 | Mikhail et al. | Jan 1998 | A |
5709668 | Wacks | Jan 1998 | A |
5713844 | Peyman | Feb 1998 | A |
5713858 | Heruth et al. | Feb 1998 | A |
5713859 | Finch, Jr. et al. | Feb 1998 | A |
5718382 | Jaeger | Feb 1998 | A |
5718682 | Tucker | Feb 1998 | A |
5725507 | Petrick | Mar 1998 | A |
5733336 | Neuenfeldt et al. | Mar 1998 | A |
5733400 | Gore et al. | Mar 1998 | A |
5741228 | Lambrecht et al. | Apr 1998 | A |
5743873 | Cai et al. | Apr 1998 | A |
5743891 | Tolkoff et al. | Apr 1998 | A |
5746460 | Marohl et al. | May 1998 | A |
5755780 | Finch, Jr. et al. | May 1998 | A |
5758667 | Slettenmark | Jun 1998 | A |
5769823 | Otto | Jun 1998 | A |
5773552 | Hutchings et al. | Jun 1998 | A |
5776188 | Shepherd et al. | Jul 1998 | A |
5792104 | Speckman et al. | Aug 1998 | A |
5792116 | Berg et al. | Aug 1998 | A |
5792123 | Ensminger | Aug 1998 | A |
5797886 | Roth et al. | Aug 1998 | A |
5810789 | Powers et al. | Sep 1998 | A |
5814016 | Valley et al. | Sep 1998 | A |
5824071 | Nelson et al. | Oct 1998 | A |
5830172 | Leveen et al. | Nov 1998 | A |
5833654 | Powers et al. | Nov 1998 | A |
5835563 | Navab et al. | Nov 1998 | A |
5836935 | Ashton et al. | Nov 1998 | A |
5840063 | Flaherty | Nov 1998 | A |
5843069 | Butler et al. | Dec 1998 | A |
5848989 | Villani | Dec 1998 | A |
5851221 | Rieder et al. | Dec 1998 | A |
5853394 | Tolkoff et al. | Dec 1998 | A |
5868702 | Stevens et al. | Feb 1999 | A |
5879322 | Lattin et al. | Mar 1999 | A |
5882341 | Bousquet | Mar 1999 | A |
5882353 | VanBeek et al. | Mar 1999 | A |
5895424 | Steele, Sr. et al. | Apr 1999 | A |
5897528 | Schultz | Apr 1999 | A |
5899856 | Schoendorfer et al. | May 1999 | A |
5904934 | Maruyama et al. | May 1999 | A |
5906592 | Kriesel et al. | May 1999 | A |
5906596 | Tallarida | May 1999 | A |
5908413 | Lange et al. | Jun 1999 | A |
5908414 | Otto et al. | Jun 1999 | A |
5911706 | Estabrook et al. | Jun 1999 | A |
5913998 | Butler et al. | Jun 1999 | A |
5916263 | Goicoechea et al. | Jun 1999 | A |
5919160 | Sanfilippo, II | Jul 1999 | A |
5925017 | Kriesel et al. | Jul 1999 | A |
5925030 | Gross et al. | Jul 1999 | A |
5927345 | Samson | Jul 1999 | A |
5928197 | Niehoff | Jul 1999 | A |
5928744 | Hellmann et al. | Jul 1999 | A |
5931829 | Burbank et al. | Aug 1999 | A |
5941856 | Kovacs et al. | Aug 1999 | A |
5944023 | Johnson et al. | Aug 1999 | A |
5944688 | Lois | Aug 1999 | A |
5944698 | Fischer et al. | Aug 1999 | A |
5944712 | Frassica et al. | Aug 1999 | A |
D413672 | Fogarty | Sep 1999 | S |
5947953 | Ash et al. | Sep 1999 | A |
5951512 | Dalton | Sep 1999 | A |
5951522 | Rosato et al. | Sep 1999 | A |
5951929 | Wilson | Sep 1999 | A |
5954687 | Baudino | Sep 1999 | A |
5954691 | Prosl | Sep 1999 | A |
5957890 | Mann et al. | Sep 1999 | A |
5961497 | Larkin | Oct 1999 | A |
5968011 | Larsen et al. | Oct 1999 | A |
5970162 | Kawashima | Oct 1999 | A |
5989216 | Johnson et al. | Nov 1999 | A |
5989239 | Finch et al. | Nov 1999 | A |
5989641 | Dulie | Nov 1999 | A |
5997524 | Burbank et al. | Dec 1999 | A |
6007516 | Burbank et al. | Dec 1999 | A |
6013051 | Nelson | Jan 2000 | A |
6013058 | Prosl et al. | Jan 2000 | A |
6017331 | Watts et al. | Jan 2000 | A |
6022335 | Ramadan | Feb 2000 | A |
6033389 | Cornish | Mar 2000 | A |
6039712 | Fogarty et al. | Mar 2000 | A |
6056717 | Finch et al. | May 2000 | A |
6077756 | Lin et al. | Jun 2000 | A |
6086555 | Eliasen et al. | Jul 2000 | A |
6090066 | Schnell | Jul 2000 | A |
6099508 | Bousquet | Aug 2000 | A |
6102884 | Squitieri | Aug 2000 | A |
6113572 | Galley et al. | Sep 2000 | A |
6120492 | Finch et al. | Sep 2000 | A |
6132415 | Finch et al. | Oct 2000 | A |
6152909 | Bagaoisan et al. | Nov 2000 | A |
6161033 | Kuhn | Dec 2000 | A |
6171198 | Lizama Troncoso et al. | Jan 2001 | B1 |
6171298 | Matsuura et al. | Jan 2001 | B1 |
6186982 | Gross et al. | Feb 2001 | B1 |
6190352 | Haarala et al. | Feb 2001 | B1 |
6193684 | Burbank et al. | Feb 2001 | B1 |
6198807 | DeSena | Mar 2001 | B1 |
6200338 | Solomon et al. | Mar 2001 | B1 |
6203570 | Baeke | Mar 2001 | B1 |
6210366 | Sanfilippo, II | Apr 2001 | B1 |
6213973 | Eliasen et al. | Apr 2001 | B1 |
6228088 | Miller et al. | May 2001 | B1 |
6251059 | Apple et al. | Jun 2001 | B1 |
D445175 | Bertheas | Jul 2001 | S |
6261259 | Bell | Jul 2001 | B1 |
6269148 | Jessop et al. | Jul 2001 | B1 |
6272370 | Gillies et al. | Aug 2001 | B1 |
6287293 | Jones et al. | Sep 2001 | B1 |
6290677 | Arai et al. | Sep 2001 | B1 |
6305413 | Fischer et al. | Oct 2001 | B1 |
6306124 | Jones et al. | Oct 2001 | B1 |
D450115 | Bertheas | Nov 2001 | S |
6315762 | Recinella et al. | Nov 2001 | B1 |
6332874 | Eliasen et al. | Dec 2001 | B1 |
6351513 | Bani-Hashemi et al. | Feb 2002 | B1 |
6355021 | Nielsen et al. | Mar 2002 | B1 |
6356782 | Sirimanne et al. | Mar 2002 | B1 |
6361557 | Gittings et al. | Mar 2002 | B1 |
6398764 | Finch, Jr. et al. | Jun 2002 | B1 |
6419680 | Cosman et al. | Jul 2002 | B1 |
6450937 | Mercereau et al. | Sep 2002 | B1 |
6459772 | Wiedenhoefer et al. | Oct 2002 | B1 |
6471674 | Emig et al. | Oct 2002 | B1 |
6473638 | Ferek-Petric | Oct 2002 | B2 |
6475516 | DiCosmo et al. | Nov 2002 | B2 |
6478783 | Moorehead | Nov 2002 | B1 |
6482217 | Pintor et al. | Nov 2002 | B1 |
6494867 | Elver et al. | Dec 2002 | B1 |
6497062 | Koopman et al. | Dec 2002 | B1 |
6500155 | Sasso | Dec 2002 | B2 |
6503228 | Li et al. | Jan 2003 | B1 |
6527754 | Tallarida et al. | Mar 2003 | B1 |
6537255 | Raines | Mar 2003 | B1 |
RE38074 | Recinella et al. | Apr 2003 | E |
6562023 | Marrs et al. | May 2003 | B1 |
6572583 | Olsen et al. | Jun 2003 | B1 |
6582418 | Verbeek et al. | Jun 2003 | B1 |
6592571 | Verbeek et al. | Jul 2003 | B1 |
6610031 | Chin | Aug 2003 | B1 |
6613002 | Clark et al. | Sep 2003 | B1 |
6613662 | Wark et al. | Sep 2003 | B2 |
6626936 | Stinson | Sep 2003 | B2 |
D480942 | Ishida et al. | Oct 2003 | S |
6629950 | Levin | Oct 2003 | B1 |
6632217 | Harper et al. | Oct 2003 | B2 |
6652486 | Bialecki et al. | Nov 2003 | B2 |
6652503 | Bradley | Nov 2003 | B1 |
6663646 | Shah | Dec 2003 | B1 |
6676633 | Smith et al. | Jan 2004 | B2 |
6697664 | Kienzle, III et al. | Feb 2004 | B2 |
6699219 | Emig et al. | Mar 2004 | B2 |
6705316 | Blythe et al. | Mar 2004 | B2 |
6719721 | Okazaki et al. | Apr 2004 | B1 |
6719739 | Verbeek et al. | Apr 2004 | B2 |
6726063 | Stull et al. | Apr 2004 | B2 |
6726678 | Nelson et al. | Apr 2004 | B1 |
6738531 | Funahashi | May 2004 | B1 |
6755842 | Kanner et al. | Jun 2004 | B2 |
6758841 | Haarala et al. | Jul 2004 | B2 |
6767356 | Kanner et al. | Jul 2004 | B2 |
6784783 | Scoggin et al. | Aug 2004 | B2 |
6808738 | DiTizio et al. | Oct 2004 | B2 |
D498894 | Gould | Nov 2004 | S |
6826257 | Sayre et al. | Nov 2004 | B2 |
6827709 | Fujii | Dec 2004 | B2 |
6852106 | Watson et al. | Feb 2005 | B2 |
6856055 | Michaels et al. | Feb 2005 | B2 |
6878136 | Fleury et al. | Apr 2005 | B2 |
6878137 | Benchetrit | Apr 2005 | B2 |
6929631 | Brugger et al. | Aug 2005 | B1 |
6949084 | Marggi et al. | Sep 2005 | B2 |
6953453 | Recinella et al. | Oct 2005 | B2 |
6962577 | Tallarida et al. | Nov 2005 | B2 |
6962580 | Adams et al. | Nov 2005 | B2 |
6994315 | Ryan et al. | Feb 2006 | B2 |
6997914 | Smith et al. | Feb 2006 | B2 |
7008377 | Beane et al. | Mar 2006 | B2 |
7008412 | Maginot | Mar 2006 | B2 |
7016456 | Basu et al. | Mar 2006 | B2 |
7018361 | Gillespie, Jr. et al. | Mar 2006 | B2 |
D518573 | French | Apr 2006 | S |
7033335 | Haarala et al. | Apr 2006 | B2 |
7033339 | Lynn | Apr 2006 | B1 |
7044942 | Jolly et al. | May 2006 | B2 |
7056316 | Burbank et al. | Jun 2006 | B1 |
7070591 | Adams et al. | Jul 2006 | B2 |
7072704 | Bucholz | Jul 2006 | B2 |
7074232 | Kanner et al. | Jul 2006 | B2 |
7076305 | Imran et al. | Jul 2006 | B2 |
7083593 | Stultz | Aug 2006 | B2 |
7108686 | Burke et al. | Sep 2006 | B2 |
7123690 | Brown et al. | Oct 2006 | B1 |
7124570 | Blatter et al. | Oct 2006 | B2 |
7127040 | Sayre et al. | Oct 2006 | B2 |
7131962 | Estabrook et al. | Nov 2006 | B1 |
7140769 | Kay | Nov 2006 | B2 |
7186236 | Gibson et al. | Mar 2007 | B2 |
7191011 | Cantlon | Mar 2007 | B2 |
7198631 | Kanner et al. | Apr 2007 | B2 |
7214207 | Lynch et al. | May 2007 | B2 |
7214215 | Heinzerling et al. | May 2007 | B2 |
7223257 | Shubayev et al. | May 2007 | B2 |
7229417 | Foerster et al. | Jun 2007 | B2 |
7232429 | Moreci | Jun 2007 | B2 |
7235067 | Morris et al. | Jun 2007 | B2 |
D546440 | Burnside | Jul 2007 | S |
7242982 | Singhal et al. | Jul 2007 | B2 |
7248668 | Galkin | Jul 2007 | B2 |
7252469 | Zaluzec et al. | Aug 2007 | B2 |
7252649 | Sherry | Aug 2007 | B2 |
7261705 | Edoga et al. | Aug 2007 | B2 |
D550355 | Racz et al. | Sep 2007 | S |
D554253 | Komerup | Oct 2007 | S |
7275682 | Excoffier et al. | Oct 2007 | B2 |
7276075 | Callas et al. | Oct 2007 | B1 |
D556153 | Burnside | Nov 2007 | S |
7306579 | Fujii | Dec 2007 | B2 |
7311702 | Tallarida et al. | Dec 2007 | B2 |
7318816 | Bobroff et al. | Jan 2008 | B2 |
7318818 | Yashiro et al. | Jan 2008 | B2 |
7322953 | Redinger | Jan 2008 | B2 |
D562442 | Blateri | Feb 2008 | S |
D562443 | Zinn et al. | Feb 2008 | S |
7331130 | Schweikert | Feb 2008 | B2 |
7331948 | Skarda | Feb 2008 | B2 |
7333013 | Berger | Feb 2008 | B2 |
D564449 | Dewberry | Mar 2008 | S |
7347838 | Kulli | Mar 2008 | B2 |
7347843 | Adams et al. | Mar 2008 | B2 |
7351233 | Parks | Apr 2008 | B2 |
7377915 | Rasmussen et al. | May 2008 | B2 |
D574950 | Zawacki et al. | Aug 2008 | S |
7413564 | Morris et al. | Aug 2008 | B2 |
D578203 | Bizup | Oct 2008 | S |
7445614 | Bunodiere et al. | Nov 2008 | B2 |
D582032 | Bizup et al. | Dec 2008 | S |
7465847 | Fabian | Dec 2008 | B2 |
7485148 | Wozencroft et al. | Feb 2009 | B2 |
7497850 | Halili | Mar 2009 | B2 |
D590499 | Chesnin | Apr 2009 | S |
7552853 | Mas et al. | Jun 2009 | B2 |
7553298 | Hunt et al. | Jun 2009 | B2 |
D595892 | Smith et al. | Jul 2009 | S |
7563025 | Kay | Jul 2009 | B2 |
7618411 | Appling | Nov 2009 | B2 |
7628776 | Gibson et al. | Dec 2009 | B2 |
7658196 | Ferreri et al. | Feb 2010 | B2 |
D612479 | Lawacki et al. | Mar 2010 | S |
D613394 | Linden | Apr 2010 | S |
7713251 | Tallarida et al. | May 2010 | B2 |
7722580 | Dicarlo et al. | May 2010 | B2 |
D619242 | Zinn et al. | Jul 2010 | S |
7766880 | Spinoza | Aug 2010 | B1 |
7785302 | Powers | Aug 2010 | B2 |
7803143 | Tallarida et al. | Sep 2010 | B2 |
7806888 | Frassica | Oct 2010 | B2 |
7811266 | Eliasen | Oct 2010 | B2 |
D629503 | Caffey et al. | Dec 2010 | S |
7846139 | Zinn et al. | Dec 2010 | B2 |
7850660 | Uth et al. | Dec 2010 | B2 |
7862546 | Conlon et al. | Jan 2011 | B2 |
D634840 | Lombardi, III et al. | Mar 2011 | S |
7909804 | Stats | Mar 2011 | B2 |
7931619 | Diamond et al. | Apr 2011 | B2 |
7947022 | Amin et al. | May 2011 | B2 |
7959615 | Stats et al. | Jun 2011 | B2 |
7972314 | Bizup et al. | Jul 2011 | B2 |
8007474 | Uth et al. | Aug 2011 | B2 |
8021324 | Bizup et al. | Sep 2011 | B2 |
8025639 | Powers et al. | Sep 2011 | B2 |
8029482 | Maniar et al. | Oct 2011 | B2 |
D650475 | Smith et al. | Dec 2011 | S |
8075536 | Gray et al. | Dec 2011 | B2 |
8092435 | Beling et al. | Jan 2012 | B2 |
8147455 | Butts et al. | Apr 2012 | B2 |
8172894 | Schmid et al. | May 2012 | B2 |
8172896 | McNamara et al. | May 2012 | B2 |
8177762 | Beasley et al. | May 2012 | B2 |
8182453 | Eliasen | May 2012 | B2 |
8197454 | Mann et al. | Jun 2012 | B2 |
8202259 | Evans et al. | Jun 2012 | B2 |
8257325 | Schweikert et al. | Sep 2012 | B2 |
D676955 | Orome | Feb 2013 | S |
8366687 | Girard et al. | Feb 2013 | B2 |
8377034 | Tallarida et al. | Feb 2013 | B2 |
8382723 | Powers et al. | Feb 2013 | B2 |
8382724 | Maniar et al. | Feb 2013 | B2 |
8409153 | Tallarida et al. | Apr 2013 | B2 |
8475417 | Powers et al. | Jul 2013 | B2 |
8545460 | Beasley et al. | Oct 2013 | B2 |
8585660 | Murphy | Nov 2013 | B2 |
8585663 | Powers et al. | Nov 2013 | B2 |
8603052 | Powers et al. | Dec 2013 | B2 |
8608712 | Bizup et al. | Dec 2013 | B2 |
8608713 | Beasley et al. | Dec 2013 | B2 |
8641676 | Butts et al. | Feb 2014 | B2 |
8641688 | Powers et al. | Feb 2014 | B2 |
8805478 | Powers et al. | Aug 2014 | B2 |
8852160 | Schweikert et al. | Oct 2014 | B2 |
8932271 | Hamatake et al. | Jan 2015 | B2 |
8939947 | Maniar et al. | Jan 2015 | B2 |
8998860 | Sheetz et al. | Apr 2015 | B2 |
9079004 | Wiley et al. | Jul 2015 | B2 |
9248268 | Wiley et al. | Feb 2016 | B2 |
9265912 | Draper et al. | Feb 2016 | B2 |
9295733 | Trieu | Mar 2016 | B2 |
9421352 | Butts et al. | Aug 2016 | B2 |
9474888 | Wiley et al. | Oct 2016 | B2 |
9579496 | Evans et al. | Feb 2017 | B2 |
9603992 | Powers | Mar 2017 | B2 |
9603993 | Powers | Mar 2017 | B2 |
9642986 | Beasley | May 2017 | B2 |
9682186 | Powers et al. | Jun 2017 | B2 |
9717895 | Wiley et al. | Aug 2017 | B2 |
9937337 | Powers et al. | Apr 2018 | B2 |
10016585 | Powers et al. | Jul 2018 | B2 |
10052470 | Powers et al. | Aug 2018 | B2 |
10052471 | Hamatake et al. | Aug 2018 | B2 |
10086186 | Evans et al. | Oct 2018 | B2 |
10092725 | Beasley | Oct 2018 | B2 |
10155101 | Wiley et al. | Dec 2018 | B2 |
10183157 | Powers et al. | Jan 2019 | B2 |
10238850 | Maniar et al. | Mar 2019 | B2 |
10265512 | Wiley et al. | Apr 2019 | B2 |
10307581 | Hibdon et al. | Jun 2019 | B2 |
10556090 | Beasley | Feb 2020 | B2 |
10625065 | Owers et al. | Apr 2020 | B2 |
10661068 | Powers et al. | May 2020 | B2 |
10675401 | Powers et al. | Jun 2020 | B2 |
20010016699 | Burbank et al. | Aug 2001 | A1 |
20010016717 | Haarala et al. | Aug 2001 | A1 |
20010047165 | Makower et al. | Nov 2001 | A1 |
20010051766 | Gazdzinski | Dec 2001 | A1 |
20010053889 | Marggi et al. | Dec 2001 | A1 |
20010056266 | Tallarida et al. | Dec 2001 | A1 |
20020013557 | Sherry | Jan 2002 | A1 |
20020052576 | Massengale | May 2002 | A1 |
20020055715 | Young et al. | May 2002 | A1 |
20020095205 | Edwin et al. | Jul 2002 | A1 |
20020121530 | Socier | Sep 2002 | A1 |
20020138068 | Watson et al. | Sep 2002 | A1 |
20020169418 | Menzi et al. | Nov 2002 | A1 |
20020173769 | Gray et al. | Nov 2002 | A1 |
20020173772 | Olsen | Nov 2002 | A1 |
20020183846 | Kuslich et al. | Dec 2002 | A1 |
20020188282 | Greenberg | Dec 2002 | A1 |
20030028173 | Forsberg | Feb 2003 | A1 |
20030032918 | Quinn | Feb 2003 | A1 |
20030093029 | McGuckin et al. | May 2003 | A1 |
20030109856 | Sherry | Jun 2003 | A1 |
20030130627 | Smith et al. | Jul 2003 | A1 |
20030135388 | Martucci et al. | Jul 2003 | A1 |
20030139812 | Garcia et al. | Jul 2003 | A1 |
20030141477 | Miller | Jul 2003 | A1 |
20030181878 | Tallarida et al. | Sep 2003 | A1 |
20030191452 | Meglin et al. | Oct 2003 | A1 |
20030208184 | Burke et al. | Nov 2003 | A1 |
20030216694 | Tollini | Nov 2003 | A1 |
20030217659 | Yamamoto et al. | Nov 2003 | A1 |
20040002693 | Bright et al. | Jan 2004 | A1 |
20040006316 | Patton | Jan 2004 | A1 |
20040019266 | Marciante | Jan 2004 | A1 |
20040020462 | Sauler et al. | Feb 2004 | A1 |
20040020492 | Dubrul et al. | Feb 2004 | A1 |
20040024361 | Fago et al. | Feb 2004 | A1 |
20040044306 | Lynch et al. | Mar 2004 | A1 |
20040054352 | Adams et al. | Mar 2004 | A1 |
20040056266 | Suh et al. | Mar 2004 | A1 |
20040064110 | Forsell | Apr 2004 | A1 |
20040073196 | Adams et al. | Apr 2004 | A1 |
20040078000 | Borchard et al. | Apr 2004 | A1 |
20040086568 | Ditizio et al. | May 2004 | A1 |
20040087877 | Besz et al. | May 2004 | A1 |
20040087885 | Kawano et al. | May 2004 | A1 |
20040106878 | Skujins et al. | Jun 2004 | A1 |
20040106891 | Langan et al. | Jun 2004 | A1 |
20040106942 | Taylor et al. | Jun 2004 | A1 |
20040116901 | Appling | Jun 2004 | A1 |
20040133173 | Edoga et al. | Jul 2004 | A1 |
20040156472 | Galkin | Aug 2004 | A1 |
20040157952 | Soffiati et al. | Aug 2004 | A1 |
20040158207 | Hunn et al. | Aug 2004 | A1 |
20040167543 | Mazzocchi et al. | Aug 2004 | A1 |
20040176743 | Morris et al. | Sep 2004 | A1 |
20040186444 | Daly et al. | Sep 2004 | A1 |
20040199129 | DiMatteo | Oct 2004 | A1 |
20040199220 | Cantlon | Oct 2004 | A1 |
20040204692 | Eliasen | Oct 2004 | A1 |
20040204759 | Blom et al. | Oct 2004 | A1 |
20040225254 | Tanaka et al. | Nov 2004 | A1 |
20040254536 | Conlon et al. | Dec 2004 | A1 |
20040254537 | Conlon et al. | Dec 2004 | A1 |
20050010176 | Dikeman et al. | Jan 2005 | A1 |
20050010286 | Vijay | Jan 2005 | A1 |
20050027234 | Waggoner et al. | Feb 2005 | A1 |
20050027261 | Weaver et al. | Feb 2005 | A1 |
20050038390 | Fago et al. | Feb 2005 | A1 |
20050044759 | Schweikert | Mar 2005 | A1 |
20050049553 | Triplett et al. | Mar 2005 | A1 |
20050070875 | Kulessa | Mar 2005 | A1 |
20050075614 | Bunodiere et al. | Apr 2005 | A1 |
20050080401 | Peavey | Apr 2005 | A1 |
20050085778 | Parks | Apr 2005 | A1 |
20050086071 | Fox et al. | Apr 2005 | A1 |
20050113806 | De Carvalho et al. | May 2005 | A1 |
20050124980 | Sanders | Jun 2005 | A1 |
20050131352 | Conlon et al. | Jun 2005 | A1 |
20050148866 | Gunderson | Jul 2005 | A1 |
20050148869 | Masuda | Jul 2005 | A1 |
20050148956 | Conlon et al. | Jul 2005 | A1 |
20050148957 | Girard et al. | Jul 2005 | A1 |
20050152841 | Sayre et al. | Jul 2005 | A1 |
20050171502 | Daly et al. | Aug 2005 | A1 |
20050182857 | Kong | Aug 2005 | A1 |
20050209573 | Brugger et al. | Sep 2005 | A1 |
20050215874 | Wang et al. | Sep 2005 | A1 |
20050241203 | Lizotte et al. | Nov 2005 | A1 |
20050256451 | Adams et al. | Nov 2005 | A1 |
20050256500 | Fujii | Nov 2005 | A1 |
20050277899 | Conlon et al. | Dec 2005 | A1 |
20050283119 | Uth et al. | Dec 2005 | A1 |
20060009788 | Freeman et al. | Jan 2006 | A1 |
20060017341 | Hahn et al. | Jan 2006 | A1 |
20060020256 | Bell et al. | Jan 2006 | A1 |
20060084929 | Eliasen | Apr 2006 | A1 |
20060089619 | Ginggen | Apr 2006 | A1 |
20060100592 | Eliasen | May 2006 | A1 |
20060116648 | Hamatake | Jun 2006 | A1 |
20060149189 | Diamond et al. | Jul 2006 | A1 |
20060171980 | Helmus et al. | Aug 2006 | A1 |
20060173410 | Moberg et al. | Aug 2006 | A1 |
20060173424 | Conlon | Aug 2006 | A1 |
20060178647 | Stats | Aug 2006 | A1 |
20060178648 | Barron et al. | Aug 2006 | A1 |
20060184141 | Smith et al. | Aug 2006 | A1 |
20060184142 | Schon et al. | Aug 2006 | A1 |
20060217359 | Wentworth et al. | Sep 2006 | A1 |
20060217659 | Patton | Sep 2006 | A1 |
20060217668 | Schulze et al. | Sep 2006 | A1 |
20060224128 | Lurvey et al. | Oct 2006 | A1 |
20060224129 | Beasley et al. | Oct 2006 | A1 |
20060224235 | Rucker | Oct 2006 | A1 |
20060241465 | Huennekens et al. | Oct 2006 | A1 |
20060247584 | Sheetz et al. | Nov 2006 | A1 |
20060253076 | Butts et al. | Nov 2006 | A1 |
20060264897 | Lobl et al. | Nov 2006 | A1 |
20060264898 | Beasley et al. | Nov 2006 | A1 |
20060271012 | Canaud et al. | Nov 2006 | A1 |
20070003603 | Karandikar et al. | Jan 2007 | A1 |
20070004981 | Boese et al. | Jan 2007 | A1 |
20070007839 | Lin | Jan 2007 | A1 |
20070010881 | Soye et al. | Jan 2007 | A1 |
20070016162 | Burbank et al. | Jan 2007 | A1 |
20070049806 | Adams et al. | Mar 2007 | A1 |
20070049876 | Patton | Mar 2007 | A1 |
20070055290 | Lober | Mar 2007 | A1 |
20070073250 | Schneiter | Mar 2007 | A1 |
20070078391 | Wortley et al. | Apr 2007 | A1 |
20070078416 | Eliasen | Apr 2007 | A1 |
20070078432 | Halseth et al. | Apr 2007 | A1 |
20070083111 | Hossack et al. | Apr 2007 | A1 |
20070083156 | Muto et al. | Apr 2007 | A1 |
20070100302 | Dicarlo et al. | May 2007 | A1 |
20070112332 | Harding et al. | May 2007 | A1 |
20070120683 | Flippen et al. | May 2007 | A1 |
20070123831 | Haindl et al. | May 2007 | A1 |
20070135775 | Edoga et al. | Jun 2007 | A1 |
20070149920 | Michels et al. | Jun 2007 | A1 |
20070149921 | Michels et al. | Jun 2007 | A1 |
20070149947 | Byrum | Jun 2007 | A1 |
20070161958 | Glenn | Jul 2007 | A1 |
20070179456 | Glenn | Aug 2007 | A1 |
20070185462 | Byrum | Aug 2007 | A1 |
20070191773 | Wojcik | Aug 2007 | A1 |
20070207335 | Karandikar et al. | Sep 2007 | A1 |
20070208313 | Conlon et al. | Sep 2007 | A1 |
20070219510 | Zinn et al. | Sep 2007 | A1 |
20070233017 | Zinn et al. | Oct 2007 | A1 |
20070233018 | Bizup et al. | Oct 2007 | A1 |
20070233042 | Moehle et al. | Oct 2007 | A1 |
20070255226 | Tennican et al. | Nov 2007 | A1 |
20070255234 | Haase et al. | Nov 2007 | A1 |
20070270691 | Bailey et al. | Nov 2007 | A1 |
20070270770 | Bizup | Nov 2007 | A1 |
20070276344 | Bizup et al. | Nov 2007 | A1 |
20070276355 | Nielsen et al. | Nov 2007 | A1 |
20070282308 | Bell | Dec 2007 | A1 |
20070293800 | McMaken et al. | Dec 2007 | A1 |
20070299408 | Alferness et al. | Dec 2007 | A1 |
20080004642 | Birk et al. | Jan 2008 | A1 |
20080008654 | Clarke et al. | Jan 2008 | A1 |
20080015701 | Garcia et al. | Jan 2008 | A1 |
20080021392 | Lurvey et al. | Jan 2008 | A1 |
20080039820 | Sommers et al. | Feb 2008 | A1 |
20080048855 | Berger | Feb 2008 | A1 |
20080051731 | Schweikert et al. | Feb 2008 | A1 |
20080108949 | Beasley et al. | May 2008 | A1 |
20080114308 | di Palma et al. | May 2008 | A1 |
20080133265 | Silkaitis et al. | Jun 2008 | A1 |
20080137923 | Spahn | Jun 2008 | A1 |
20080138387 | Machiraju | Jun 2008 | A1 |
20080208236 | Hobbs et al. | Aug 2008 | A1 |
20080281279 | Hoendervoogt et al. | Nov 2008 | A1 |
20080319398 | Bizup | Dec 2008 | A1 |
20080319399 | Schweikert et al. | Dec 2008 | A1 |
20080319405 | Bizup | Dec 2008 | A1 |
20090024024 | Zinn | Jan 2009 | A1 |
20090024098 | Bizup et al. | Jan 2009 | A1 |
20090035582 | Nakatani et al. | Feb 2009 | A1 |
20090118612 | Grunwald et al. | May 2009 | A1 |
20090118683 | Hanson et al. | May 2009 | A1 |
20090156928 | Evans et al. | Jun 2009 | A1 |
20090204072 | Amin et al. | Aug 2009 | A1 |
20090204074 | Powers et al. | Aug 2009 | A1 |
20090216216 | Powers et al. | Aug 2009 | A1 |
20090221976 | Linden | Sep 2009 | A1 |
20090227862 | Smith et al. | Sep 2009 | A1 |
20090227951 | Powers et al. | Sep 2009 | A1 |
20090227964 | DiCarlo et al. | Sep 2009 | A1 |
20090264901 | Franklin et al. | Oct 2009 | A1 |
20090264990 | Bruszewski et al. | Oct 2009 | A1 |
20090315684 | Sacco et al. | Dec 2009 | A1 |
20090322541 | Jones et al. | Dec 2009 | A1 |
20100010339 | Smith et al. | Jan 2010 | A1 |
20100042073 | Oster et al. | Feb 2010 | A1 |
20100063451 | Gray et al. | Mar 2010 | A1 |
20100069743 | Sheetz et al. | Mar 2010 | A1 |
20100106094 | Fisher et al. | Apr 2010 | A1 |
20100121283 | Hamatake et al. | May 2010 | A1 |
20100211026 | Mr. Sheetz et al. | Aug 2010 | A2 |
20100268165 | Maniar et al. | Oct 2010 | A1 |
20100268174 | Steinke et al. | Oct 2010 | A1 |
20100319700 | Ng et al. | Dec 2010 | A1 |
20110021922 | Berard-Anderson et al. | Jan 2011 | A1 |
20110054312 | Bell et al. | Mar 2011 | A1 |
20110092921 | Beling et al. | Apr 2011 | A1 |
20110098662 | Zinn | Apr 2011 | A1 |
20110098663 | Zinn | Apr 2011 | A1 |
20110118677 | Wiley et al. | May 2011 | A1 |
20110160673 | Magalich et al. | Jun 2011 | A1 |
20110183712 | Eckstein et al. | Jul 2011 | A1 |
20110213700 | Sant'Anselmo | Sep 2011 | A1 |
20110257609 | Bizup et al. | Oct 2011 | A1 |
20110264058 | Linden et al. | Oct 2011 | A1 |
20110271856 | Fisher et al. | Nov 2011 | A1 |
20110275930 | Jho et al. | Nov 2011 | A1 |
20110276015 | Powers et al. | Nov 2011 | A1 |
20110288502 | Hibdon et al. | Nov 2011 | A1 |
20110288503 | Magalich et al. | Nov 2011 | A1 |
20110311337 | Amin et al. | Dec 2011 | A1 |
20120018073 | Maniar et al. | Jan 2012 | A1 |
20120059250 | Gray et al. | Mar 2012 | A1 |
20120065622 | Cornish et al. | Mar 2012 | A1 |
20120078201 | Mikami | Mar 2012 | A1 |
20120078202 | Beling et al. | Mar 2012 | A1 |
20120191071 | Butts et al. | Jul 2012 | A1 |
20120226244 | Beasley et al. | Sep 2012 | A1 |
20120259296 | Sheetz et al. | Oct 2012 | A1 |
20120283560 | Schweikert et al. | Nov 2012 | A1 |
20120302969 | Wiley et al. | Nov 2012 | A1 |
20130165773 | Powers et al. | Jun 2013 | A1 |
20130172733 | Maniar et al. | Jul 2013 | A1 |
20130218103 | Tallarida et al. | Aug 2013 | A1 |
20130225990 | Powers et al. | Aug 2013 | A1 |
20130225991 | Powers | Aug 2013 | A1 |
20130245574 | Powers et al. | Sep 2013 | A1 |
20130338494 | Wiley et al. | Dec 2013 | A1 |
20140058275 | Gregorich et al. | Feb 2014 | A1 |
20140081219 | Powers et al. | Mar 2014 | A1 |
20140100534 | Beasley et al. | Apr 2014 | A1 |
20140107619 | Butts et al. | Apr 2014 | A1 |
20140330118 | Powers et al. | Nov 2014 | A1 |
20140350396 | Powers et al. | Nov 2014 | A1 |
20150008891 | Li et al. | Jan 2015 | A1 |
20150025478 | Hibdon et al. | Jan 2015 | A1 |
20150088091 | Beasley et al. | Mar 2015 | A1 |
20150112284 | Hamatake et al. | Apr 2015 | A1 |
20150290445 | Powers et al. | Oct 2015 | A1 |
20150290446 | Wiley et al. | Oct 2015 | A1 |
20170028185 | Wiley et al. | Feb 2017 | A1 |
20170157383 | Evans et al. | Jun 2017 | A1 |
20170232232 | Beasley | Aug 2017 | A1 |
20170246441 | Powers et al. | Aug 2017 | A1 |
20170319842 | Wiley et al. | Nov 2017 | A1 |
20180161565 | Maniar et al. | Jun 2018 | A1 |
20180311488 | Powers et al. | Nov 2018 | A1 |
20180353743 | Hamatake et al. | Dec 2018 | A1 |
20190038871 | Beasley | Feb 2019 | A1 |
20190060628 | Evans et al. | Feb 2019 | A1 |
20190111242 | Wiley et al. | Apr 2019 | A1 |
20190111243 | Powers et al. | Apr 2019 | A1 |
20190151641 | Powers et al. | May 2019 | A1 |
20190217073 | Maniar et al. | Jul 2019 | A1 |
20190252603 | Wiley et al. | Aug 2019 | A1 |
20190275311 | Hibdon et al. | Sep 2019 | A1 |
20200086105 | Powers et al. | Mar 2020 | A1 |
20200171278 | Beasley | Jun 2020 | A1 |
Number | Date | Country |
---|---|---|
2008299945 | Mar 2009 | AU |
2663853 | Apr 2008 | CA |
2692142 | Dec 2008 | CA |
2693972 | Jan 2009 | CA |
2757836 | May 2017 | CA |
102421469 | Apr 2012 | CN |
102612343 | Jul 2012 | CN |
3618390 | Nov 1987 | DE |
3720414 | Dec 1987 | DE |
42 25 524 | Feb 1994 | DE |
29512576 | Oct 1995 | DE |
10346470 | May 2005 | DE |
10 2009 018837 | Nov 2010 | DE |
0128525 | Dec 1984 | EP |
0134745 | Mar 1985 | EP |
0343910 | Nov 1989 | EP |
0366814 | May 1990 | EP |
0239244 | Sep 1991 | EP |
0534782 | Mar 1993 | EP |
0537892 | Apr 1993 | EP |
0619101 | Oct 1994 | EP |
1238682 | Sep 2002 | EP |
1486229 | Dec 2004 | EP |
1635899 | Mar 2006 | EP |
1858565 | Nov 2007 | EP |
1874393 | Jan 2008 | EP |
1896117 | Mar 2008 | EP |
1998842 | Dec 2008 | EP |
2004272 | Dec 2008 | EP |
2018209 | Jan 2009 | EP |
2081634 | Jul 2009 | EP |
2164559 | Mar 2010 | EP |
2167182 | Mar 2010 | EP |
2180915 | May 2010 | EP |
2190517 | Jun 2010 | EP |
2320974 | May 2011 | EP |
2324879 | May 2011 | EP |
2365838 | Sep 2011 | EP |
2571563 | Mar 2013 | EP |
2601999 | Jun 2013 | EP |
2324879 | Jan 2014 | EP |
2324878 | Aug 2014 | EP |
2308547 | Sep 2014 | EP |
2324880 | Dec 2014 | EP |
1 965 854 | Sep 2015 | EP |
2939703 | Mar 2017 | EP |
2416828 | Feb 2018 | EP |
1509165 | Jan 1968 | FR |
2508008 | Dec 1982 | FR |
2809315 | Nov 2001 | FR |
178998 | May 1922 | GB |
749942 | Jun 1956 | GB |
966137 | Aug 1964 | GB |
1559140 | Jan 1980 | GB |
2102398 | Feb 1983 | GB |
2191701 | Dec 1987 | GB |
2350352 | Nov 2000 | GB |
62155857 | Jul 1987 | JP |
62281966 | Dec 1987 | JP |
64-011562 | Jan 1989 | JP |
H05-200107 | Aug 1993 | JP |
6296633 | Oct 1994 | JP |
2000-79168 | Mar 2000 | JP |
2000-079168 | Mar 2000 | JP |
2002500076 | Jan 2002 | JP |
2002-83281 | Mar 2002 | JP |
2002-209910 | Jul 2002 | JP |
2002-531149 | Sep 2002 | JP |
2003-510136 | Mar 2003 | JP |
2004-350937 | Dec 2004 | JP |
2006-500087 | Jan 2006 | JP |
2007-203070 | Aug 2007 | JP |
2007-275548 | Oct 2007 | JP |
2007-533368 | Nov 2007 | JP |
3142990 | Jul 2008 | JP |
2008-539025 | Nov 2008 | JP |
2009-077965 | Apr 2009 | JP |
2009-142520 | Jul 2009 | JP |
2009-540932 | Nov 2009 | JP |
2012-523284 | Oct 2012 | JP |
2012-236040 | Dec 2012 | JP |
2013-510652 | Mar 2013 | JP |
2013-526376 | Jun 2013 | JP |
6018822 | Nov 2016 | JP |
8600213 | Jan 1986 | WO |
1986000213 | Jan 1986 | WO |
9818506 | May 1989 | WO |
1989011309 | Nov 1989 | WO |
9001958 | Mar 1990 | WO |
1990001958 | Mar 1990 | WO |
9206732 | Apr 1992 | WO |
1993000945 | Jan 1993 | WO |
9305730 | Apr 1993 | WO |
1993005730 | Apr 1993 | WO |
1993008986 | May 1993 | WO |
9405351 | Mar 1994 | WO |
9516480 | Jun 1995 | WO |
1995015194 | Jun 1995 | WO |
96-35477 | Nov 1996 | WO |
9701370 | Jan 1997 | WO |
1997001370 | Jan 1997 | WO |
1997006845 | Feb 1997 | WO |
9711726 | Apr 1997 | WO |
9723255 | Jul 1997 | WO |
9726931 | Jul 1997 | WO |
1998017337 | Apr 1998 | WO |
1998031417 | Jul 1998 | WO |
9910250 | Mar 1999 | WO |
1999034859 | Jul 1999 | WO |
9938553 | Aug 1999 | WO |
9942166 | Aug 1999 | WO |
0012171 | Mar 2000 | WO |
016844 | Mar 2000 | WO |
0020050 | Apr 2000 | WO |
033901 | Jun 2000 | WO |
2000033901 | Jun 2000 | WO |
0123023 | Apr 2001 | WO |
2001023023 | Apr 2001 | WO |
0160444 | Aug 2001 | WO |
0170304 | Sep 2001 | WO |
2001095813 | Dec 2001 | WO |
0247549 | Jun 2002 | WO |
2002047549 | Jun 2002 | WO |
03030962 | Apr 2003 | WO |
03084832 | Oct 2003 | WO |
03090509 | Nov 2003 | WO |
2004004800 | Jan 2004 | WO |
2004012787 | Feb 2004 | WO |
2004028611 | Apr 2004 | WO |
2004071555 | Aug 2004 | WO |
2004091434 | Oct 2004 | WO |
2005037055 | Apr 2005 | WO |
2005068009 | Jul 2005 | WO |
2005072627 | Aug 2005 | WO |
2005089833 | Sep 2005 | WO |
2006078915 | Jul 2006 | WO |
2006096686 | Sep 2006 | WO |
2006116438 | Nov 2006 | WO |
2006116613 | Nov 2006 | WO |
2006130133 | Dec 2006 | WO |
2006134100 | Dec 2006 | WO |
2007041471 | Apr 2007 | WO |
2007079024 | Jul 2007 | WO |
2007092210 | Aug 2007 | WO |
2007094898 | Aug 2007 | WO |
2007098771 | Sep 2007 | WO |
2007109164 | Sep 2007 | WO |
2007126645 | Nov 2007 | WO |
2007136538 | Nov 2007 | WO |
2007149546 | Dec 2007 | WO |
2008008126 | Jan 2008 | WO |
2008024440 | Feb 2008 | WO |
2008019236 | Feb 2008 | WO |
2008048461 | Apr 2008 | WO |
2008048361 | Apr 2008 | WO |
2008062173 | May 2008 | WO |
2008063226 | May 2008 | WO |
2008147760 | Dec 2008 | WO |
2008157763 | Dec 2008 | WO |
2009002839 | Dec 2008 | WO |
2009012385 | Jan 2009 | WO |
2009012395 | Jan 2009 | WO |
2009035582 | Mar 2009 | WO |
2009046439 | Apr 2009 | WO |
2009046725 | Apr 2009 | WO |
2009108669 | Sep 2009 | WO |
2010030351 | Mar 2010 | WO |
2010062633 | Jun 2010 | WO |
2010118144 | Oct 2010 | WO |
2011046604 | Apr 2011 | WO |
2011053499 | May 2011 | WO |
2011056619 | May 2011 | WO |
2011062750 | May 2011 | WO |
2011133950 | Oct 2011 | WO |
2011146649 | Nov 2011 | WO |
2013165935 | Nov 2013 | WO |
2014031763 | Feb 2014 | WO |
Entry |
---|
Fallscheer, et al., “Injury to the Upper Extremity Cuased by Extravasation of Contrast Medium: A True Emergency.” Scandinavian Journal of Plastic and Reconstructive Surgery and Hand Surgery, vol. 41, pp. 26-32, 2007. |
Fresenius Brochure on Intraport 1, Intraport II, and Bioport (Nov. 1998). |
Fresenius, Intraport II Instructions for Use. |
Gebauer, B. et al., “Contrast Media Power Injection Using Central Venous Port Catheters—Results of an In-Vitro Study,” Experimental Radiology 2005: 177: 1417-1423. |
Gebauer, B. et al., “Contrast Media Power Injection Using Central Venous Port Catheters—Results of an In-Vitro Study,” Experimental Radiology 2005: 177: 1417-1423.—Translation. |
Herts, B. R., “Power Injection of Contrast Media Using Central Venous Catheters: Feasibility, Safety, and Efficacy” AJR 2001;176:447-453, Feb. 2001. |
HMO 2002 Product Catalog, 2002. |
Hou, Shaw-Min et al. “Comparisons of Outcomes and Survivals for Two Central Venous Access Port Systems.” Journal of Surgical Oncology, 91:61-66, 2005. |
Inamed Health, BioEnterics® Lap-Band® “Adjustable Gastric Banding System” Product Brochure, Dec. 2003. |
Johnson, Kathleen A., “Power Injectable Portal Systems.” Journal of Radiology Nursing, vol. 28, Issue 1, Mar. 2009. |
JP 2007-558331 filed Mar. 6, 2006 Office Action dated Aug. 20, 2013. |
JP 2007-558331 filed Mar. 6, 2006 Office Action dated Jan. 22, 2013. |
JP 2007-558331 filed Mar. 6, 2006 Office Action dated May 17, 2011. |
JP 2008-509056 filed Apr. 25, 2006 Office Action dated Apr. 4, 2012. |
JP 2008-509056 filed Apr. 25, 2006 Office Action dated Jun. 7, 2011. |
JP 2012-156976 filed Jul. 12, 2012 Notice of Reasons for Refusal dated Apr. 8, 2014. |
JP 2012-156976 filed Jul. 12, 2012 Notice of Reasons for Refusal dated Aug. 27, 2013. |
JP 2012-156976 filed Jul. 12, 2012 Office Action dated Jun. 28, 2016. |
JP 2012-156976 filed Jul. 12, 2012 Submission of Documents by Third Party dated May 14, 2013. |
JP 2012-156976 filed Mar. 6, 2006, Office Action dated Mar. 29, 2016. |
JP 2012-156976 filed Mar. 6, 2006, Third Party Submission dated Jul. 29, 2015. |
JP 2012-504826 filed Oct. 6, 2011 First Office Action dated Mar. 4, 2014. |
JP 2012-504826 filed Oct. 6, 2011 Second Office Action dated Nov. 17, 2014. |
JP 2013-209156 filed Oct. 4, 2013 Non-Final Office Action dated Oct. 7, 2014. |
JP 2013-511339 filed Nov. 16, 2012 First Office Action dated Feb. 19, 2015. |
JP 2013-511339 filed Nov. 16, 2012 Office Action and Pre-Appeal Report dated Apr. 12, 2016. |
JP 2013-511339 filed Nov. 16, 2012 Office Action dated Dec. 16, 2016. |
JP 2013-511339 filed Nov. 16, 2012 Second Office Action dated Oct. 16, 2015. |
JP 2015-501762 filed Sep. 16, 2014 First Office Action dated Oct. 5, 2016. |
JP 2015-501762 filed Sep. 16, 2014 Office Action dated Feb. 1, 2017. |
JP 2015-501762 filed Sep. 16, 2014 Office Action dated Jan. 16, 2018. |
JP 2015-528624 filed Feb. 20, 2015 Office Action dated Apr. 25, 2018. |
JP 2015-528624 filed Feb. 20, 2015 Office Action dated May 31, 2017. |
JP 2016-026954 filed Feb. 16, 2016 Office Action dated Aug. 16, 2017. |
JP 2016-026954 filed Feb. 16, 2016 Office Action dated Dec. 15, 2016. |
JP 6018822 filed Jul. 12, 2012 Request for Trial for Invalidation dated May 22, 2017. |
JP2012-156976 filed Jul. 12, 2012 Amendment filed on Jul. 13, 2016 (Ref D06 of Request for Trial for Invalidation dated May 22, 2017). |
JP2012-156976 filed Jul. 12, 2012 Amendment filed on Mar. 3, 2016 (Ref D04 of Request for Trial for Invalidation dated May 22, 2017). |
JP2012-156976 filed Jul. 12, 2012 Amendment filed on Oct. 28, 2013 (Ref D03 of Request for Trial for Invalidation dated May 22, 2017). |
JP2012-156976 filed Jul. 12, 2012 Office Action dated Aug. 20, 2013 (Ref D07 of Request for Trial for Invalidation dated May 22, 2017). |
JP2012-156976 filed Jul. 12, 2012 Remarks filed on Mar. 3, 2016 (Ref D05 of Request for Trial for Invalidation dated May 22, 2017). |
Kaste et al., “Safe use of power injectors with central and peripheral venous access devices for pediatric CT,” Pediatr Radiol (1996) 26: 499-501. |
KR 10-2011-7026328 filed Nov. 4, 2011 Notice of Last Preliminary Rejection dated Dec. 28, 2016. |
KR 10-2011-7026328 filed Nov. 4, 2011 Notice of Preliminary Rejection dated Jun. 20, 2016. |
KR 10-2017-7014546 filed May 29, 2017 Office Action dated Aug. 23, 2017. |
KR 10-2017-7014546 filed May 29, 2017 Office Action dated Feb. 27, 2018. |
L-Cath® for Ports, Luther Medical Products, Inc., Tustin, California, 2 pages, 1994. |
LaMaitre Vascular “Port Implantations: using the OptiLock Implantable Port,” product information, available at http://www.lemaitre. com/specs.pop.asp, last accessed Apr. 2003, 14 pages. |
LAP-BAND AP™ “System with Adjustable Gastric Banding system with Omniform™ Design,” Product Brochure, Jul. 2007, 16 pages. |
LAP-BAND® System Access Port Fill Guide I, “9.75/10.0 cm LAP-BAND System vs. 11 cm LAP-BAND System: For Product Manufactured Prior to Jul. 2001” BioEnterics Corporation. Rev. B. Aug. 15, 2001. |
CA 2,864,047 filed Aug. 6, 2014 Office Action dated Apr. 23, 2019. |
CN 201610037718.7 filed Jan. 20, 2016 Office Action dated Mar. 1, 2019. |
EP 098241953 filed Apr. 13, 2011 Office Action dated Apr. 10, 2019. |
EP 13764254.2 filed Sep. 10, 2014 Office Action dated Mar. 25, 2019. |
U.S. Appl. No. 14/104,354, filed Dec. 12, 2013 Non-Final Office Action dated Sep. 4, 2019. |
U.S. Appl. No. 14/508,227, filed Oct. 7, 2014 Notice of Allowance dated Feb. 4, 2019. |
U.S. Appl. No. 15/594,288, filed May 12, 2017 Non-Final Office Action dated Aug. 21, 2019. |
U.S. Appl. No. 16/105,725, filed Aug. 20, 2018 Non-Final Office Action dated Sep. 18, 2019. |
U.S. Appl. No. 16/153,488, filed Oct. 5, 2018 Notice of Allowance dated Sep. 18, 2019. |
U.S. Appl. No. 14/104,354, filed Dec. 12, 2013 Non-Final Office Action dated Feb. 26, 2016. |
U.S. Appl. No. 14/104,354, filed Dec. 12, 2013 Non-Final Office Action dated Nov. 22, 2016. |
U.S. Appl. No. 14/141,263, filed Dec. 26, 2013 Notice of Allowance dated Apr. 20, 2016. |
U.S. Appl. No. 14/171,364, filed Feb. 3, 2014 Decision on Appeal dated Feb. 23, 2018. |
U.S. Appl. No. 14/171,364, filed Feb. 3, 2014 Examiner's Answer dated Jul. 29, 2016. |
U.S. Appl. No. 14/171,364, filed Feb. 3, 2014 Final Office Action dated Jun. 25, 2015. |
U.S. Appl. No. 14/171,364, filed Feb. 3, 2014 Non-Final Office Action dated Feb. 12, 2015. |
U.S. Appl. No. 14/171,364, filed Feb. 3, 2014 Notice of Allowance dated Mar. 26, 2018. |
U.S. Appl. No. 14/455,660, filed Aug. 8, 2014 Final Office Action dated May 19, 2017. |
U.S. Appl. No. 14/455,660, filed Aug. 8, 2014 Final Office Action dated Nov. 27, 2015. |
U.S. Appl. No. 14/455,660, filed Aug. 8, 2014 Non-Final Office Action dated Jul. 6, 2015. |
U.S. Appl. No. 14/455,660, filed Aug. 8, 2014 Non-Final Office Action dated Mar. 18, 2015. |
U.S. Appl. No. 14/455,660, filed Aug. 8, 2014 Non-Final Office Action dated Oct. 14, 2016. |
U.S. Appl. No. 14/455,660, filed Aug. 8, 2014 Notice of Allowance dated Nov. 24, 2017. |
U.S. Appl. No. 14/508,227, filed Oct. 7, 2014 Non-Final Office Action dated Jun. 15, 2018. |
U.S. Appl. No. 14/508,227, filed Oct. 7, 2014 Restriction Requirement dated Apr. 20, 2018. |
U.S. Appl. No. 14/587,862, filed Dec. 31, 2014 Advisory Action dated Aug. 18, 2017. |
U.S. Appl. No. 14/587,862, filed Dec. 31, 2014 Final Office Action dated May 4, 2017. |
U.S. Appl. No. 14/587,862, filed Dec. 31, 2014 Non-Final Office Action dated Nov. 3, 2016. |
U.S. Appl. No. 14/587,862, filed Dec. 31, 2014 Non-Final Office Action dated Sep. 28, 2017. |
U.S. Appl. No. 14/587,862, filed Dec. 31, 2014 Notice of Allowance dated Apr. 6, 2018. |
U.S. Appl. No. 14/599,376, filed Jan. 16, 2015 Advisory Action dated Aug. 23, 2016. |
U.S. Appl. No. 14/599,376, filed Jan. 16, 2015 Final Office Action dated Jun. 8, 2016. |
U.S. Appl. No. 14/599,376, filed Jan. 16, 2015 Final Office Action dated May 16, 2017. |
U.S. Appl. No. 14/599,376, filed Jan. 16, 2015 Non-Final Office Action dated Feb. 3, 2016. |
U.S. Appl. No. 14/599,376, filed Jan. 16, 2015 Non-Final Office Action dated May 14, 2018. |
U.S. Appl. No. 14/599,376, filed Jan. 16, 2015 Non-Final Office Action dated Nov. 7, 2016. |
U.S. Appl. No. 14/599,376, filed Jan. 16, 2015 Notice of Allowance dated Nov. 6, 2018. |
U.S. Appl. No. 14/748,917, filed Jun. 24, 2015 Notice of Allowance dated May 9, 2018. |
U.S. Appl. No. 14/750,174, filed Jun. 25, 2015 Non-Final Office Action dated Nov. 1, 2016. |
U.S. Appl. No. 14/750,174, filed Jun. 25, 2015 Notice of Allowance dated Mar. 10, 2017. |
U.S. Appl. No. 15/043,450, filed Feb. 12, 2016 Final Office Action dated Mar. 29, 2018. |
U.S. Appl. No. 15/043,450, filed Feb. 12, 2016 Non-Final Office Action dated Nov. 30, 2017. |
U.S. Appl. No. 15/290,621, filed Oct. 11, 2016 Non-Final Office Action dated May 16, 2018. |
U.S. Appl. No. 15/290,621, filed Oct. 11, 2016 Notice of Allowance dated Dec. 13, 2018. |
U.S. Appl. No. 15/442,371, filed Feb. 24, 2017 Non-Final Office Action dated Mar. 20, 2018. |
U.S. Appl. No. 15/585,030, filed May 2, 2017 Notice of Allowance dated May 29, 2018. |
U.S. Appl. No. 15/660,513, filed Jul. 26, 2017 Restriction Requirement dated Mar. 15, 2018. |
U.S. Appl. No. 15/881,616, filed Jan. 26, 2018 Final Office Action dated Aug. 6, 2018. |
U.S. Appl. No. 15/881,616, filed Jan. 26, 2018 Non-Final Office Action dated Mar. 28, 2018. |
U.S. Appl. No. 16/029,103, filed Jul. 6, 2018 Notice of Allowance dated Sep. 4, 2018. |
U.S. Appl. No. 29/239,163, filed Sep. 27, 2005 entitled Injectable Power Port, listing Eddie K. Burnside as inventor. |
U.S. Appl. No. 29/247,954, filed Jul. 21, 2006 entitled Injectable Power Port, listing Eddie K. Burnside as inventor. |
U.S. Appl. No. 29/247,954, filed Jul. 21, 2006 Non-Final Office Action dated Apr. 6, 2007. |
U.S. Appl. No. 29/247,954, filed Jul. 21, 2006 Notice of Allowability dated Jul. 30, 2007. |
U.S. Appl. No. 29/284,454, filed Sep. 7, 2007 titled Implantable Port Device, listing John A. Zawacki and Annmarie Boswell as inventors, in which a Continued Prosecution Application was filed on Jan. 30, 2008. |
U.S. Appl. No. 29/284,456, filed Sep. 7, 2007, titled Implantable Port Device, listing John A. Zawacki and Annemarie Boswell as inventors. |
U.S. Appl. No. 29/382,235, filed Dec. 30, 2010 Non-Final Office Action dated Oct. 3, 2012. |
U.S. Appl. No. 29/382,246, filed Dec. 30, 2010 Notice of Allowance dated Oct. 3, 2012. |
U.S. Appl. No. 95/002,089, filed Aug. 20, 2012 Action Closing Prosecution dated Jun. 12, 2013. |
C.A. No. 15-218-SLR-SRF, Invalidity Contentions Exhibit A46 dated Jun. 24, 2016. |
C.A. No. 15-218-SLR-SRF, Invalidity Contentions Exhibit A47 dated Jun. 24, 2016. |
C.A. No. 15-218-SLR-SRF, Invalidity Contentions Exhibit A48 dated Jun. 24, 2016. |
C.A. No. 15-218-SLR-SRF, Invalidity Contentions Exhibit A49 dated Jun. 24, 2016. |
C.A. No. 15-218-SLR-SRF, Invalidity Contentions Exhibit A5 dated Jun. 24, 2016. |
C.A. No. 15-218-SLR-SRF, Invalidity Contentions Exhibit A50 dated Jun. 24, 2016. |
C.A. No. 15-218-SLR-SRF, Invalidity Contentions Exhibit A51 dated Jun. 24, 2016. |
C.A. No. 15-218-SLR-SRF, Invalidity Contentions Exhibit A6 dated Jun. 24, 2016. |
C.A. No. 15-218-SLR-SRF, Invalidity Contentions Exhibit A7 dated Jun. 24, 2016. |
C.A. No. 15-218-SLR-SRF, Invalidity Contentions Exhibit A8 dated Jun. 24, 2016. |
C.A. No. 15-218-SLR-SRF, Invalidity Contentions Exhibit A9 dated Jun. 24, 2016. |
C.A. No. 15-218-SLR-SRF, Invalidity Contentions Exhibit B1 dated Jun. 24, 2016. |
C.A. No. 15-218-SLR-SRF, Invalidity Contentions Exhibit B10 dated Jun. 24, 2016. |
C.A. No. 15-218-SLR-SRF, Invalidity Contentions Exhibit B11 dated Jun. 24, 2016. |
C.A. No. 15-218-SLR-SRF, Invalidity Contentions Exhibit B12 dated Jun. 24, 2016. |
C.A. No. 15-218-SLR-SRF, Invalidity Contentions Exhibit B13 dated Jun. 24, 2016. |
C.A. No. 15-218-SLR-SRF, Invalidity Contentions Exhibit B14 dated Jun. 24, 2016. |
C.A. No. 15-218-SLR-SRF, Invalidity Contentions Exhibit B15 dated Jun. 24, 2016. |
C.A. No. 15-218-SLR-SRF, Invalidity Contentions Exhibit B16 dated Jun. 24, 2016. |
C.A. No. 15-218-SLR-SRF, Invalidity Contentions Exhibit B17 dated Jun. 24, 2016. |
C.A. No. 15-218-SLR-SRF, Invalidity Contentions Exhibit B18 dated Jun. 24, 2016. |
C.A. No. 15-218-SLR-SRF, Invalidity Contentions Exhibit B19 dated Jun. 24, 2016. |
C.A. No. 15-218-SLR-SRF, Invalidity Contentions Exhibit B2 dated Jun. 24, 2016. |
C.A. No. 15-218-SLR-SRF, Invalidity Contentions Exhibit B20 dated Jun. 24, 2016. |
C.A. No. 15-218-SLR-SRF, Invalidity Contentions Exhibit B21 dated Jun. 24, 2016. |
C.A. No. 15-218-SLR-SRF, Invalidity Contentions Exhibit B22 dated Jun. 24, 2016. |
C.A. No. 15-218-SLR-SRF, Invalidity Contentions Exhibit B23 dated Jun. 24, 2016. |
C.A. No. 15-218-SLR-SRF, Invalidity Contentions Exhibit B24 dated Jun. 24, 2016. |
C.A. No. 15-218-SLR-SRF, Invalidity Contentions Exhibit B25 dated Jun. 24, 2016. |
C.A. No. 15-218-SLR-SRF, Invalidity Contentions Exhibit B26 dated Jun. 24, 2016. |
C.A. No. 15-218-SLR-SRF, Invalidity Contentions Exhibit B27 dated Jun. 24, 2016. |
C.A. No. 15-218-SLR-SRF, Invalidity Contentions Exhibit B28 dated Jun. 24, 2016. |
C.A. No. 15-218-SLR-SRF, Invalidity Contentions Exhibit B29 dated Jun. 24, 2016. |
C.A. No. 15-218-SLR-SRF, Invalidity Contentions Exhibit B3 dated Jun. 24, 2016. |
C.A. No. 15-218-SLR-SRF, Invalidity Contentions Exhibit B30 dated Jun. 24, 2016. |
C.A. No. 15-218-SLR-SRF, Invalidity Contentions Exhibit B31 dated Jun. 24, 2016. |
C.A. No. 15-218-SLR-SRF, Invalidity Contentions Exhibit B32 dated Jun. 24, 2016. |
C.A. No. 15-218-SLR-SRF, Invalidity Contentions Exhibit B33 dated Jun. 24, 2016. |
C.A. No. 15-218-SLR-SRF, Invalidity Contentions Exhibit B4 dated Jun. 24, 2016. |
C.A. No. 15-218-SLR-SRF, Invalidity Contentions Exhibit B5 dated Jun. 24, 2016. |
C.A. No. 15-218-SLR-SRF, Invalidity Contentions Exhibit B6 dated Jun. 24, 2016. |
C.A. No. 15-218-SLR-SRF, Invalidity Contentions Exhibit B7 dated Jun. 24, 2016. |
C.A. No. 15-218-SLR-SRF, Invalidity Contentions Exhibit B8 dated Jun. 24, 2016. |
C.A. No. 15-218-SLR-SRF, Invalidity Contentions Exhibit B9 dated Jun. 24, 2016. |
C.A. No. 15-218-SLR-SRF, Invalidity Contentions Exhibit C1 dated Jun. 24, 2016. |
C.A. No. 15-218-SLR-SRF, Invalidity Contentions Exhibit C2 dated Jun. 24, 2016. |
C.A. No. 15-218-SLR-SRF, Invalidity Contentions Exhibit C3 dated Jun. 24, 2016. |
C.A. No. 15-218-SLR-SRF, Invalidity Contentions Exhibit C4 dated Jun. 24, 2016. |
C.A. No. 15-218-SLR-SRF, Invalidity Contentions Exhibit C5 dated Jun. 24, 2016. |
C.A. No. 15-218-SLR-SRF, Invalidity Contentions Exhibit C6 dated Jun. 24, 2016. |
U.S. Appl. No. 12/917,323, filed Nov. 1, 2010 Final Office Action dated Jan. 29, 2011. |
U.S. Appl. No. 12/917,323, filed Nov. 1, 2010 Non-Final Office Action dated Aug. 15, 2012. |
U.S. Appl. No. 12/917,323, filed Nov. 1, 2010 Non-Final Office Action dated Aug. 26, 2014. |
U.S. Appl. No. 12/917,323, filed Nov. 1, 2010 Notice of Allowance dated Jan. 21, 2015. |
U.S. Appl. No. 12/419,854, filed Apr. 7, 2009 Non-Final Office Action dated Aug. 5, 2011. |
U.S. Appl. No. 13/110,734, filed May 18, 2011 Non-Final Office Action dated Jul. 7, 2014. |
U.S. Appl. No. 13/113,834, filed May 23, 2011 Final Office Action dated Nov. 23, 2012. |
U.S. Appl. No. 13/113,834, filed May 23, 2011 Non-Final Office Action dated Jul. 17, 2012. |
U.S. Appl. No. 13/159,230, filed Jun. 13, 2011 Notice of Allowance dated Aug. 1, 2012. |
U.S. Appl. No. 13/250,909, filed Sep. 30, 2011 Notice of Allowance dated Aug. 6, 2012. |
U.S. Appl. No. 13/438,586, filed Apr. 3, 2012 Advisory Action dated May 29, 2011. |
U.S. Appl. No. 13/438,586, filed Apr. 3, 2012 Final Office Action dated Mar. 7, 2013. |
U.S. Appl. No. 13/438,586, filed Apr. 3, 2012 Non-Final Office Action dated Sep. 19, 2012. |
U.S. Appl. No. 13/438,586, filed Apr. 3, 2012 Notice of Allowance dated Sep. 16, 2013. |
U.S. Appl. No. 13/471,219, filed May 14, 2012 Non-Final Office Action dated Jul. 10, 2013. |
U.S. Appl. No. 13/524,712, filed Jun. 15, 2012 Advisory Action dated May 7, 2014. |
U.S. Appl. No. 13/524,712, filed Jun. 15, 2012 Final Office Action dated Mar. 3, 2014. |
U.S. Appl. No. 13/524,712, filed Jun. 15, 2012 Non-Final Office Action dated Aug. 21, 2014. |
U.S. Appl. No. 13/524,712, filed Jun. 15, 2012 Non-Final Office Action dated Oct. 22, 2013. |
U.S. Appl. No. 13/524,712, filed Jun. 15, 2012 Notice of Allowance dated Dec. 12, 2014. |
U.S. Appl. No. 13/571,088, filed Aug. 9, 2012 Final Office Action dated Jul. 16, 2013. |
U.S. Appl. No. 13/571,088, filed Aug. 9, 2012 Final Office Action dated Jul. 6, 2015. |
U.S. Appl. No. 13/571,088, filed Aug. 9, 2012 Non-Final Office Action dated Feb. 27, 2013. |
U.S. Appl. No. 13/571,088, filed Aug. 9, 2012 Non-Final Office Action dated Jan. 7, 2015. |
U.S. Appl. No. 13/571,088, filed Aug. 9, 2012 Notice of Allowance dated Sep. 16, 2015. |
U.S. Appl. No. 13/776,451, filed Feb. 25, 2013 Non-Final Office Action dated Jul. 24, 2013. |
U.S. Appl. No. 13/776,517, filed Feb. 25, 2013 Final Office Action dated Jun. 30, 2014. |
U.S. Appl. No. 13/776,517, filed Feb. 25, 2013 Non-Final Office Action dated Feb. 27, 2014. |
U.S. Appl. No. 13/776,517, filed Feb. 25, 2013 Non-Final Office Action dated Nov. 15, 2013. |
U.S. Appl. No. 13/776,517, filed Feb. 25, 2013 Notice of Allowance dated Sep. 23, 2014. |
U.S. Appl. No. 13/801,893, filed Mar. 13, 2013 Notice of Allowance dated Sep. 24, 2015. |
U.S. Appl. No. 13/853,942, filed Mar. 29, 2013 Non-Final Office Action dated Jul. 26, 2013. |
U.S. Appl. No. 13/853,956, filed Mar. 29, 2013 Final Office Action dated Feb. 20, 2015. |
U.S. Appl. No. 13/853,956, filed Mar. 29, 2013 Final Office Action dated Jan. 10, 2017. |
U.S. Appl. No. 13/853,956, filed Mar. 29, 2013 Final Office Action dated Oct. 18, 2016. |
U.S. Appl. No. 13/853,956, filed Mar. 29, 2013 Non-Final Office Action dated Dec. 3, 2013. |
U.S. Appl. No. 13/853,956, filed Mar. 29, 2013 Non-Final Office Action dated Jun. 16, 2016. |
U.S. Appl. No. 13/853,956, filed Mar. 29, 2013 Non-Final Office Action dated Sep. 15, 2014. |
U.S. Appl. No. 13/853,961, filed Mar. 29, 2013 Final Office Action dated Feb. 20, 2015. |
U.S. Appl. No. 13/853,961, filed Mar. 29, 2013 Final Office Action dated Jan. 9, 2017. |
U.S. Appl. No. 13/853,961, filed Mar. 29, 2013 Non-Final Office Action dated Dec. 3, 2013. |
U.S. Appl. No. 13/853,961, filed Mar. 29, 2013 Non-Final Office Action dated Jun. 15, 2016. |
U.S. Appl. No. 13/853,961, filed Mar. 29, 2013 Non-Final Office Action dated Oct. 18, 2016. |
U.S. Appl. No. 13/853,961, filed Mar. 29, 2013 Non-Final Office Action dated Sep. 12, 2014. |
U.S. Appl. No. 13/972,538, filed Aug. 21, 2013 Non-Final Office Action dated Feb. 3, 2016. |
U.S. Appl. No. 14/083,250, filed Nov. 18, 2013 Non-Final Office Action dated Dec. 12, 2016. |
U.S. Appl. No. 14/083,250, filed Nov. 18, 2013 Non-Final Office Action dated Apr. 1, 2016. |
U.S. Appl. No. 14/104,354, filed Dec. 12, 2013 Final Office Action dated Jun. 15, 2018. |
U.S. Appl. No. 14/104,354, filed Dec. 12, 2013 Final Office Action dated Jun. 21, 2016. |
U.S. Appl. No. 14/104,354, filed Dec. 12, 2013 Final Office Action dated May 31, 2017. |
U.S. Appl. No. 95/002,089, filed Aug. 20, 2012 Decision on Appeal in U.S. Pat. No. 7,785,302, dated Mar. 11, 2016. |
U.S. Appl. No. 95/002,089, filed Aug. 20, 2012 Office Action in and Order Granting/Denying Request for Inter Partes Reexamination dated Nov. 7, 2012. |
U.S. Appl. No. 95/002,090, filed Aug. 20, 2012 Action Closing Prosecution dated Jun. 12, 2013. |
U.S. Appl. No. 95/002,090, filed Aug. 20, 2012 Decision on Appeal in U.S. Pat. No. 7,947,022, dated Mar. 29, 2016. |
U.S. Appl. No. 95/002,090, filed Aug. 20, 2012 Office Action in and Order Granting/Denying Request for Inter Partes Reexamination dated Nov. 7, 2012. |
U.S. Appl. No. 95/002,092, filed Aug. 20, 2012 Action Closing Prosecution dated Jun. 12, 2013. |
U.S. Appl. No. 95/002,092, filed Aug. 20, 2012 Decision on Appeal in U.S. Pat. No. 7,959,615, dated Mar. 24, 2016. |
U.S. Appl. No. 95/002,092, filed Aug. 20, 2012 Office Action in and Order Granting/Denying Request for Inter Partes Reexamination dated Nov. 13, 2012. |
Vergara, et al., “Adverse Reactions to Contrast Medica in CT: Effects of Temperature and Ionic Property.” Radiology, vol. 199, No. 2, May 1996. |
Virot et al. “Long-term use of hemodialysis rooms LifeSite” Nephrologie vol. 24, No. 8, pp. 443-449 (2003). |
Vogelzang, Robert L., “Power Injection Through Central Venous Catheters: Physiological and Hemodynamic Considerations.” The McGaw Medical Center of Northwestern University, Feinberg School of Medicine. Jun. 23, 2004. |
Wells, S. “Venous Access in Oncology and Haematology Patients: Part One.” Nursing Standard, vol. 22, No. 52, pp. 39-46, Sep. 3, 2008. |
Wikipedia, “Port Catheter”, Dec. 15, 2011. |
Williamson, et al., “Assessing the Adequacy of Peripherally Inserted Central Catheters for Power Injection of Intravenous Contrast Agents for CT.” Journal of Computer Assisted Tomography, vol. 6, No. 6, pp. 932-937, 2001. |
Buerger et al “Implantation of a new device for haemodialysis” Nephrol. Dial. Transplant 15: 722-724 (2000). |
C. R. Bard, Inc. and Bard Peripheral Vascular, Inc., v. Angiodynamics, Inc., C.A. No. 15-218-JFB-SRF, Angiodynamics's Answer to Supplemental Complaint, Counterclaims Against Bard Peripheral Vascular, and Crossclaims/Third Party Complaint Against C.R. Bard public version dated Aug. 25, 2017. [Redacted]. |
C. R. Bard, Inc. and Bard Peripheral Vascular, Inc., v. Angiodynamics, Inc., C.A. No. 15-218-SLR-SRF, Angiodynamics, Inc.'s Initial Invalidity Contentions dated Jun. 24, 2016. |
C. R. Bard, Inc. and Bard Peripheral Vascular, Inc., v. Angiodynamics, Inc., C.A. No. 15-218-SLR-SRF, Defendant and Counterclaim-Plaintiff Angiodynamics's Identification of Invalidity References dated Mar. 15, 2017. |
C. R. Bard, Inc. and Bard Peripheral Vascular, Inc., v. Angiodynamics, Inc., C.A. No. 15-218-SLR-SRF, Expert Report of Timothy Clark, MD, MD, FSIR Regarding Infringement of the Patents-In-Suit dated Nov. 30, 2017. [Redacted]. |
C. R. Bard, Inc. and Bard Peripheral Vascular, Inc., v. Angiodynamics, Inc., C.A. No. 1:15-cv-00218-JFB-SRF, Opening Expert Report of Robert L. Vogelzang, M.D. Regarding Invalidity of U.S. Pat. No. 8,475,417, U.S. Pat. No. 8,545,460 & U.S. Pat. No. 3,805,478 dated Sep. 1, 2017. [Redacted]. |
C. R. Bard, Inc. and Bard Peripheral Vascular, Inc., v. Medical Components, Inc., C.A. No. 2:17-cv-00754-TS, Defendant's Initial Noninfringement, Unenforceability, and Invalidity Contentions dated Nov. 28, 2017. |
C. R. Bard, Inc. and Bard Peripheral Vascular, Inc., v. Medical Components, Inc., C.A. No. 2:17-cv-00754-TS, Defendant's Second Amended Answer to Plaintiffs' First Amended Complaint and Second Amended Counterclaims Dated Nov. 7, 2017. |
C. R. Bard, Inc. and Bard Peripheral Vascular, Inc., v. Medical Components, Inc., C.A. No. 2:17-cv-00754-TS, Plaintiffs' Motion to Dismiss Medcomp's Inequitable Conduct Counterclaims and to Strike Medcomp's Inequitable Conduct Affirmative Defenses dated Oct. 16, 2017. |
C. R. Bard, Inc. v Innovative Medical Devices, LLC; Medical Components, Inc. “Petition for Inter Partes Review of U.S. Pat. No. 8,852,160” dated Jul. 31, 2015. |
C.A. No. 15-218-SLR-SRF, Invalidity Contentions Exhibit A1 dated Jun. 24, 2016. |
C.A. No. 15-218-SLR-SRF, Invalidity Contentions Exhibit A10 dated Jun. 24, 2016. |
C.A. No. 15-218-SLR-SRF, Invalidity Contentions Exhibit A11 dated Jun. 24, 2016. |
C.A. No. 15-218-SLR-SRF, Invalidity Contentions Exhibit A12 dated Jun. 24, 2016. |
C.A. No. 15-218-SLR-SRF, Invalidity Contentions Exhibit A13 dated Jun. 24, 2016. |
C.A. No. 15-218-SLR-SRF, Invalidity Contentions Exhibit A14 dated Jun. 24, 2016. |
C.A. No. 15-218-SLR-SRF, Invalidity Contentions Exhibit A15 dated Jun. 24, 2016. |
C.A. No. 15-218-SLR-SRF, Invalidity Contentions Exhibit A16 dated Jun. 24, 2016. |
C.A. No. 15-218-SLR-SRF, Invalidity Contentions Exhibit A17 dated Jun. 24, 2016. |
C.A. No. 15-218-SLR-SRF, Invalidity Contentions Exhibit A18 dated Jun. 24, 2016. |
C.A. No. 15-218-SLR-SRF, Invalidity Contentions Exhibit A19 dated Jun. 24, 2016. |
C.A. No. 15-218-SLR-SRF, Invalidity Contentions Exhibit A2 dated Jun. 24, 2016. |
C.A. No. 15-218-SLR-SRF, Invalidity Contentions Exhibit A20 dated Jun. 24, 2016. |
C.A. No. 15-218-SLR-SRF, Invalidity Contentions Exhibit A21 dated Jun. 24, 2016. |
C.A. No. 15-218-SLR-SRF, Invalidity Contentions Exhibit A22 dated Jun. 24, 2016. |
C.A. No. 15-218-SLR-SRF, Invalidity Contentions Exhibit A23 dated Jun. 24, 2016. |
C.A. No. 15-218-SLR-SRF, Invalidity Contentions Exhibit A24 dated Jun. 24, 2016. |
C.A. No. 15-218-SLR-SRF, Invalidity Contentions Exhibit A25 dated Jun. 24, 2016. |
C.A. No. 15-218-SLR-SRF, Invalidity Contentions Exhibit A26 dated Jun. 24, 2016. |
C.A. No. 15-218-SLR-SRF, Invalidity Contentions Exhibit A27 dated Jun. 24, 2016. |
C.A. No. 15-218-SLR-SRF, Invalidity Contentions Exhibit A28 dated Jun. 24, 2016. |
C.A. No. 15-218-SLR-SRF, Invalidity Contentions Exhibit A29 dated Jun. 24, 2016. |
C.A. No. 15-218-SLR-SRF, Invalidity Contentions Exhibit A3 dated Jun. 24, 2016. |
C.A. No. 15-218-SLR-SRF, Invalidity Contentions Exhibit A30 dated Jun. 24, 2016. |
C.A. No. 15-218-SLR-SRF, Invalidity Contentions Exhibit A31 dated Jun. 24, 2016. |
C.A. No. 15-218-SLR-SRF, Invalidity Contentions Exhibit A32 dated Jun. 24, 2016. |
C.A. No. 15-218-SLR-SRF, Invalidity Contentions Exhibit A33 dated Jun. 24, 2016. |
C.A. No. 15-218-SLR-SRF, Invalidity Contentions Exhibit A34 dated Jun. 24, 2016. |
C.A. No. 15-218-SLR-SRF, Invalidity Contentions Exhibit A35 dated Jun. 24, 2016. |
C.A. No. 15-218-SLR-SRF, Invalidity Contentions Exhibit A36 dated Jun. 24, 2016. |
C.A. No. 15-218-SLR-SRF, Invalidity Contentions Exhibit A37 dated Jun. 24, 2016. |
C.A. No. 15-218-SLR-SRF, Invalidity Contentions Exhibit A38 dated Jun. 24, 2016. |
C.A. No. 15-218-SLR-SRF, Invalidity Contentions Exhibit A39 dated Jun. 24, 2016. |
C.A. No. 15-218-SLR-SRF, Invalidity Contentions Exhibit A4 dated Jun. 24, 2016. |
C.A. No. 15-218-SLR-SRF, Invalidity Contentions Exhibit A40 dated Jun. 24, 2016. |
C.A. No. 15-218-SLR-SRF, Invalidity Contentions Exhibit A41 dated Jun. 24, 2016. |
C.A. No. 15-218-SLR-SRF, Invalidity Contentions Exhibit A42 dated Jun. 24, 2016. |
C.A. No. 15-218-SLR-SRF, Invalidity Contentions Exhibit A43 dated Jun. 24, 2016. |
C.A. No. 15-218-SLR-SRF, Invalidity Contentions Exhibit A44 dated Jun. 24, 2016. |
C.A. No. 15-218-SLR-SRF, Invalidity Contentions Exhibit A45 dated Jun. 24, 2016. |
JP 2018-077325 filed Apr. 13, 2018 Office Action dated Mar. 22, 2019. |
JP 2018-077325 filed Apr. 13, 2018 Office Action dated Sep. 5, 2019. |
JP 2018-077325 filed Apr. 13, 2018 Pre-Appeal Examination Report dated Mar. 6, 2020. |
U.S. Appl. No. 14/104,354, filed Dec. 12, 2013 Notice of Allowance dated Feb. 13, 2020. |
U.S. Appl. No. 15/594,288, filed May 12, 2017 Corrected Notice of Allowance dated May 6, 2020. |
U.S. Appl. No. 15/594,288, filed May 12, 2017 Notice of Allowance dated Mar. 10, 2020. |
U.S. Appl. No. 16/105,725, filed Aug. 20, 2018 Notice of Allowance dated Dec. 26, 2019. |
U.S. Appl. No. 16/105,774, filed Aug. 20, 2018 Final Office Action dated Apr. 17, 2020. |
U.S. Appl. No. 16/105,774, filed Aug. 20, 2018 Non-Final Office Action dated Oct. 7, 2019. |
U.S. Appl. No. 16/105,774, filed Aug. 20, 2018 Notice of Allowance dated Jun. 12, 2020. |
U.S. Appl. No. 16/252,005, filed Jan. 18, 2019 Non-Final Office Action dated May 22, 2020. |
U.S. Appl. No. 16/691,340, filed Nov. 21, 2019 Non-Final Office Action dated Jan. 8, 2020. |
U.S. Appl. No. 16/691,340, filed Nov. 21, 2019 Notice of Allowance dated Feb. 12, 2020. |
U.S. Appl. No. 11/380,621, filed Apr. 27, 2006 Final Office Action dated Mar. 8, 2011. |
U.S. Appl. No. 11/380,621, filed Apr. 27, 2006 Non-Final Office Action dated Jul. 1, 2009. |
U.S. Appl. No. 11/380,621, filed Apr. 27, 2006 Non-Final Office Action dated Jun. 6, 2008. |
U.S. Appl. No. 11/725,287, filed Mar. 19, 2007 Non-final Office Action dated Dec. 3, 2008. |
U.S. Appl. No. 11/725,287, filed Mar. 19, 2007 Non-final Office Action dated Jun. 12, 2009. |
U.S. Appl. No. 11/725,287, filed Mar. 19, 2007 Non-final Office Action dated Mar. 29, 2010. |
U.S. Appl. No. 11/937,302, filed Nov. 8, 2007 Final Office Action dated Nov. 8, 2012. |
U.S. Appl. No. 11/937,302, filed Nov. 8, 2007 Final Office Action dated Oct. 13, 2011. |
U.S. Appl. No. 11/937,302, filed Nov. 8, 2007 Non-Final Office Action dated Jun. 18, 2012. |
U.S. Appl. No. 11/937,302, filed Nov. 8, 2007 Final Office Action dated Feb. 11, 2011. |
U.S. Appl. No. 11/937,302, filed Nov. 8, 2007 Non-Final Office Action dated Apr. 15, 2011. |
U.S. Appl. No. 11/937,302, filed Nov. 8, 2007 Non-Final Office Action dated Sep. 13, 2010. |
U.S. Appl. No. 12/023,280, filed Jan. 31, 2008 Final Office Action dated Mar. 9, 2010. |
U.S. Appl. No. 12/023,280, filed Jan. 31, 2008 Non-Final Office Action dated Dec. 13, 2010. |
U.S. Appl. No. 12/023,280, filed Jan. 31, 2008 Non-Final Office Action dated Jul. 23, 2009. |
U.S. Appl. No. 12/023,280, filed Jan. 31, 2008 Non-Final Office Action dated Oct. 5, 2009. |
U.S. Appl. No. 12/023,280, filed Jan. 31, 2008 Notice of Allowance dated Mar. 28, 2011. |
U.S. Appl. No. 12/143,377, filed Jun. 20, 2008 Final Office Action dated Oct. 19, 2009. |
U.S. Appl. No. 12/143,377, filed Jun. 20, 2008 Non-final Office Action dated Apr. 27, 2009. |
U.S. Appl. No. 12/175,182, filed Jul. 17, 2008 Non-final Office Action dated Sep. 3, 2009. |
U.S. Appl. No. 12/267,160, filed Nov. 7, 2008 Examiner's Answer dated Dec. 5, 2012. |
U.S. Appl. No. 12/267,160, filed Nov. 7, 2008 Final Office Action dated Jun. 1, 2012. |
U.S. Appl. No. 12/267,160, filed Nov. 7, 2008 Non-Final Office Action dated Nov. 1, 2011. |
U.S. Appl. No. 12/419,854, filed Apr. 7, 2009 Advisory Action dated May 17, 2013. |
U.S. Appl. No. 12/419,854, filed Apr. 7, 2009 Final Office Action dated Feb. 14, 2013. |
U.S. Appl. No. 12/419,854, filed Apr. 7, 2009 Final Office Action dated Nov. 29, 2011. |
U.S. Appl. No. 12/419,854, filed Apr. 7, 2009 Non-Final Office Action dated Jun. 26, 2012. |
U.S. Appl. No. 12/419,854, filed Apr. 7, 2009 Notice of Allowance dated Apr. 7, 2014. |
U.S. Appl. No. 12/419,957, filed Apr. 7, 2009 Advisory Action dated Feb. 18, 2011. |
U.S. Appl. No. 12/419,957, filed Apr. 7, 2009 Final Office Action dated Dec. 7, 2010. |
U.S. Appl. No. 12/419,957, filed Apr. 7, 2009 Non-Final Office Action dated Feb. 18, 2010. |
U.S. Appl. No. 12/419,957, filed Apr. 7, 2009 Non-Final Office Action dated Jul. 29, 2010. |
U.S. Appl. No. 12/419,957, filed Apr. 7, 2009 Non-Final Office Action dated Jun. 30, 2009. |
U.S. Appl. No. 12/419,957, filed Apr. 7, 2009 Notice of Allowance dated Mar. 7, 2011. |
U.S. Appl. No. 12/420,007, filed Apr. 7, 2009 Final Office Action dated Mar. 22, 2013. |
U.S. Appl. No. 12/420,007, filed Apr. 7, 2009 Non-Final Office Action dated Oct. 16, 2012. |
U.S. Appl. No. 12/420,007, filed Apr. 7, 2009 Final Office Action dated Feb. 18, 2010. |
U.S. Appl. No. 12/420,007, filed Apr. 7, 2009 Non-Final Office Action dated Jul. 14, 2009. |
U.S. Appl. No. 12/420,028, filed Apr. 7, 2009 Non-Final Office Action dated Jan. 5, 2011. |
U.S. Appl. No. 12/420,028 filed Apr. 7, 2009 Notice of Allowance dated Apr. 1, 2011. |
U.S. Appl. No. 12/617,981, filed Nov. 13, 2009 Final Office Action dated Aug. 2, 2012. |
U.S. Appl. No. 12/617,981, filed Nov. 13, 2009 Advisory Action dated Sep. 15, 2011. |
U.S. Appl. No. 12/617,981, filed Nov. 13, 2009 Final Office Action dated Jun. 21, 2011. |
U.S. Appl. No. 12/617,981, filed Nov. 13, 2009 Non-Final Office Action dated Dec. 21, 2011. |
U.S. Appl. No. 12/617,981, filed Nov. 13, 2009 Non-Final Office Action dated Jan. 5, 2011. |
U.S. Appl. No. 12/796,133, filed Jun. 8, 2010 Non-Final Office Action dated Feb. 17, 2011. |
U.S. Appl. No. 12/796,133, filed Jun. 8, 2010 Notice of Allowance dated Jun. 9, 2011. |
U.S. Appl. No. 12/917,323, filed Nov. 1, 2010 Advisory Action dated Apr. 10, 2013. |
“Japanese Journal of Cancer and Chemotherapy”, 26, (13), 2055-2060, issued on Nov. 16, 1999. (Ref D18 of Request for Trial for Invalidation dated May 22, 2017). |
“Rad Fan”, 1, (3), 40-43, issued on Jul. 25, 2003 (Ref D17 of Request for Trial for Invalidation dated May 22, 2017). |
“Safety Considerations in the Power Injection of Contrast Medium via a Totally Implantable Central Venous Access System” IVR Interventional Radiology, 20, (1) 27-30, issued on Jan. 1, 2005. (Ref D09 of Request for Trial for Invalidation dated May 22, 2017). |
Allergan, Inc. LAP-BAND® System Fact Sheet. © 2007. |
Angiodynamics's Answer to Supplemental Complaint, Counterclaims Against Bard Peripheral Vascular, and Cross Claims/Third Party Complaint Against C.R. Bard. Public Version, dated Aug. 18, 2017. |
AngioDynamics, Smart Port Guidelines for Health Care Providers, 2010. |
Appendix B of Invalidity Contention Charts dated Nov. 28, 2017. |
AU 2013235532 filed Aug. 6, 2014 Office Action dated Sep. 6, 2017. |
B. Braun, Access Port Systems, Celsite® Product Information, 19 pages, Nov. 2005. |
B. Braun, Easypump Product Page, accessed May 11, 2011. |
B. Braun, Port Catheter Systems Product Page, accessed May 11, 2011. |
Bard Access Systems Mar. 21, 1995 Product Release to Market form for “M.R.I. Port with 8 Fr. ChronoFlexÓ´Catheter”, “M.R.I. Port with 8Fr. ChronoFlex Catheter with Intro-Eze™”, “M.R.I. Port with 8. Fr ChronoFlex Catheter and Peel Apart”, “M.R.I. Port with 8Fr. ChronoFlex Catheter Demo Kit”. Drawings included. |
Bard Access Systems, BardPort and X-Port Implanted Ports Brochure, © 2007. |
Bard Access Systems, BardPort, SlimPort and X-Port Instructions for Use, May 2003. |
Bard Access Systems, BardPort, SlimPort, X-Port Instructions for Use, 24 pages, Oct. 2012. |
Bard Access Systems, BardPort™ Implanted Ports Patient Information, Feb. 1993. |
Bard Access Systems, Devices for Small Patients, 4 pages, Jul. 1992. |
Bard Access Systems, Family of PICCs, 1 page, Mar. 10, 2006. |
Bard Access Systems, M.R.I. Dual Port with Septum-Finder Ridge IFU, 2 pages, © 1993. |
Bard Access Systems, Ports Brochure, © 2003. |
Bard Access Systems, PowerPort and PowerLoc CT Guide, 11 pages, Dec. 2009. |
Bard Access Systems, PowerPort and PowerLoc Product Brochure, 6 pages, © 2007. |
Bard Access Systems, PowerPort CT Guide, 16 pages, Mar. 2007. |
Bard Access Systems, PowerPort Guidelines for CT Technologists, 1 page, Feb. 2007. |
Bard Access Systems, PowerPort Guidelines for CT Technologists, 1 page, Jul. 2006. |
Bard Access Systems, PowerPort Guidelines for Nurses, 1 page, Feb. 2007. |
Bard Access Systems, PowerPort Guidelines for Physicians, 1 page, Feb. 2007. |
Bard Access Systems, PowerPort Implanted Port with Open-Ended Catheter Instructions for Use, 8 pages, Dec. 2006. |
Bard Access Systems, PowerPort Information for the Patient, 5 pages, © 2006. |
Bard Access Systems, PowerPort Prescription Pad, 1 page, © 2007. |
Bard Access Systems, PowerPort Product Brochure, 8 pages, © 2009. |
Bard Access Systems, PowerPort™ Implantable Port Product Information, © 2007. |
Bard Access Systems, Titanium Dome Implantable Port, http://www.bardacess.com, last accessed Jan. 10, 2012. |
Bard Access Systems, When in Doubt, SCOUT!, 1 page, © 2007. |
Bard Healthcare Leaflet (2001). |
BardPort, SlimPort, X-Port Instructions for Use, 2012. |
Baxter Guidelines on Port Maintainence (Jun. 2003). |
Baxter Healthport® Focus (Oct. 1999). |
Baxter Healthport® Venous Systems (Oct. 2002). |
Baxter Patient Information, Healthport® System (May 1999). |
Baxter Therapy Systems, Baxter Healthport® Jan. 1999. |
Beathard et al. “Initial clinical results with the LifeSite Hemodialysis Access System” Kidney International, vol. 58, pp. 2221-2227, (2000). |
Biffi, R. et al. “Use of totally implantable central venous access ports for high-dose chemotherapy and peripheral blood stem cell transplantation: results of a monocentre series of 376 patients.” Annals of Oncology 15:296-300, 2004. |
Biffi, R., et al. “Best Choice of Central Venous Insertion Site for the Prevention of Catheter-Related Complications in Adult Patients Who Need Cancer Therapy: A Randomized Trial.” Annals of Oncology, Jan. 29, 2009. |
Biffi, Roberto, et al. “A Randomized, Prospective Trial of Central Venous Ports Connected to Standard Open-Ended or Groshong Catheters in Adult Oncology Patients.” American Cancer Society, vol. 92, No. 5, pp. 1204-1212, Sep. 1, 2001. |
BioEnterics Corporation, LAP-BAND® “Adjustable Gastric Banding System” Product Brochure Rev. G, Nov. 2000. |
Biolink: Products—Dialock System (2002). |
Biotronik, Stratos Cardiac Resynchronization Therapy Pacemakers Technical Manual, 179 pages, © 2008. |
Boston Scientific, Xcela™ Power Injectable Picc Directions for Use, 12 pages, © 2007. |
Braun Product Catalog (Aug. 2005). |
PCT/US2008/010520 filed Sep. 8, 2008 Written Opinion dated Feb. 24, 2009. |
PCT/US2008/067679 filed Jun. 20, 2008 Search Report dated Sep. 30, 2008. |
PCT/US2008/067679 filed Jun. 20, 2008 Written Opinion dated Sep. 30, 2008. |
PCT/US2008/070330 filed Jul. 17, 2008 Search Report dated Dec. 1, 2008. |
PCT/US2008/070330 filed Jul. 17, 2008 Written Opinion dated Dec. 1, 2008. |
PCT/US2008/070345 filed Jul. 17, 2008 Search Report dated Dec. 1, 2008. |
PCT/US2008/070345 filed Jul. 17, 2008 Written Opinion dated Dec. 1, 2008. |
PCT/US2008/078976 filed Apr. 2, 2009 Search Report and Written Opinion dated Apr. 3, 2009. |
PCT/US2009/035088 filed Feb. 25, 2009 International Search Report dated May 19, 2009. |
PCT/US2009/035088 filed Feb. 25, 2009 Written Opinion dated May 19, 2009. |
PCT/US2009/062854 filed Oct. 30, 2009 International Preliminary Report on Patentability dated May 5, 2011. |
PCT/US2009/062854 filed Oct. 30, 2009 International Search Report dated Dec. 23, 2009. |
PCT/US2009/062854 filed Oct. 30, 2009 Search Report dated Dec. 23, 2009. |
PCT/US2009/062854 filed Oct. 30, 2009 Written Opinion dated Dec. 23, 2009. |
PCT/US2010/030256 filed Apr. 7, 2010 Search Report dated Jun. 4, 2010. |
PCT/US2010/030256 filed Apr. 7, 2010 Written Opinion dated Jun. 4, 2010. |
PCT/US2010/054994 filed Nov. 1, 2010 Search Report dated Jan. 10, 2011. |
PCT/US2010/054994 filed Nov. 1, 2010 Written Opinion dated Jan. 10, 2011. |
PCT/US2011/037038 filed May 18, 2011 International Preliminary Report on Patentability dated Nov. 20, 2012. |
PCT/US2011/037038 filed May 18, 2011 International Search Report and Written Opinion dated Aug. 30, 2011. |
PCT/US2011/037038 filed May 18, 2011 Written Opinion and Search Report dated Aug. 30, 2011. |
PCT/US2013/031035 filed Mar. 13, 2013 International Search Report and Written Opinion dated Jun. 3, 2013. |
PCT/US2013/056019 filed Aug. 21, 2013 International Search Report and Written Opinion dated Feb. 28, 2014. |
PCT/US99/28695 filed Dec. 3, 1999 International Preliminary Examination Report dated Apr. 21, 2001. |
PCT/US99/28695 filed Dec. 3, 1999 Search Report dated Apr. 11, 2000. |
PFM Medical, Xcela™ Power Injectable Port Directions for Use, 15 pages, © 2008. |
Picture of HMP Vortex MP Vascular Access Port from Exhibit A11, Jun. 24, 2016. |
Port-A-Cath Implantable Vascular Access Systems, brochure, (1996). |
Port-A-Cath® P.A.S. PORT® Systems by Deltec, Product Specifications, 1999. |
Port-A-Cath® “Implantable Epidural, Aterial and Peritonial Access Systems” Internet Product Listing. <<http://web.archive.org/web/20001119035900/www.deltec.com/cPacspl.htm.>> last accessed Jun. 4, 2012. |
Port-A-Cath® “Many Port-A-Cath® System Choices” Product Brochure. © 1996 SIMS Deltec, Inc. |
Port-A-Cath® & Port-A-Cath® II Dual-lumen Implantable Venous Access Systems Product Specifications, 2005. |
Port-A-Cath® II Implantable Access Systems Information Sheet, Sep. 2006. |
Proper Care of the Vortex, Nov. 30, 2000. |
Rappolt, Richard T., et al. “Radiopaque Codification and X-ray Identification of Ingested Drugs” Ingestive Radiology, May-Jun. 1966. |
Request for Inter partes Reexamination of U.S. Pat. No. 7,785,302, filed Aug. 20, 2012. |
Request for Inter partes Reexamination of U.S. Pat. No. 7,947,022, filed Aug. 20, 2012. |
Request for Inter partes Reexamination of U.S. Pat. No. 7,959,615, filed Aug. 20, 2012. |
RU 2014140544 filed Mar. 13, 2016 Office Action dated Jul. 20, 2017. |
Salis et al., “Maximal flow rates possible during power injection through currently available PICCs: An in-vitro study,” J Vasc Interv Radiol 2004; 15:275-281. |
Sandstede, Joem, “Pediatric CT,” available online at www.multislice-ct.com, MultiSLICE-CT.com, version 02, May 2, 2003. |
Sanelli, et al., “Safety and Feasibility of Using a Central Venous Catheter for Rapid Contrast Injection Rates.” American Journal of Radiology, vol. 183, pp. 1829-1834, Dec. 2004. |
Shah, Tilak M., “Radiopaque Polymer Formulations for Medical Devices.” Medical Device and Diagnostic Industry, Mar. 2000. |
Smith Medical, Port-A-Cath® “Single-lumen Implantable Vascular Access Systems” Product Specifications, 2004. |
Smith, Lisa Hartkoph, “Implanted Ports, Computed Tomography, Power Injectors, and Catheter Rupture.” Clinical Journal of Oncology Nursing, vol. 12 , No. 5. Oct. 2008. |
Smiths Medical, “Smiths Medical Launches Implantable Ports for Easy Viewing Under CT Scans” Press Release, Jan. 5, 2011. |
Soloman, et al., “CIN Strategies: Anticipate, Manage, Prevent.” Supplement to Imaging Economics, May 2007. |
Statement of Prof. Dr. med. Karl R. Aigner, Oct. 11, 2011. |
EP 06751411 filed Apr. 25, 2006 Decision Revoking the European Patent dated Aug. 1, 2012. |
EP 06751411 filed Apr. 25, 2006 Office Action dated Aug. 10, 2009. |
EP 06751411 filed Apr. 25, 2006 Opposition by Aesculap AG dated Oct. 6, 2011. |
EP 06751411 filed Apr. 25, 2006 Opposition by Fresenius Kabi Deutschland GmbH dated Oct. 11, 2011. |
EP 06751411 filed Apr. 25, 2006 Opposition by pfm medical ag dated Oct. 18, 2011. |
EP 06751664.1 filed Apr. 27, 2006 First Examination Report dated Jul. 11, 2013. |
EP 06751664.1 filed Apr. 27, 2006 Second Examination Report dated Dec. 17, 2014. |
EP 06845998 filed Dec. 21, 2006 Office Action dated Mar. 10, 2011. |
EP 06845998 filed Dec. 21, 2006 Supplementary Search Report dated Jul. 22, 2010. |
EP 06845998.1 filed Dec. 21, 2006 Examination Report dated Feb. 6, 2014. |
EP 06845998.1 filed Dec. 21, 2006 Examination Report dated May 13, 2013. |
EP 06845998.1 filed Dec. 21, 2006 Examination Report dated Nov. 7, 2012. |
EP 06845998.1 filed Dec. 21, 2006 Summons for Oral Proceedings dated Sep. 30, 2014. |
EP 09824195.3 filed Apr. 13, 2011 Extended European Search Report dated Apr. 28, 2017. |
EP 10 831 973.2 filed May 30, 2012 Extended European Search Report dated Jul. 4, 2014. |
EP 10 831 973.2 filed May 30, 2012 Intent to Grant dated Feb. 12, 2018. |
EP 10 831 973.2 filed May 30, 2012 Office Action dated Aug. 18, 2017. |
EP 10183380.4 filed Apr. 25, 2006 European Search Report dated May 22, 2013. |
EP 10183382.0 filed Apr. 25, 2006 European Search Report dated May 22, 2013. |
EP 10183382.0 filed Apr. 25, 2006 Intent to Grant dated Mar. 7, 2014. |
EP 10183394.5 filed Apr. 25, 2006 European Search Report dated May 22, 2013. |
EP 10183394.5 filed Apr. 25, 2006 interlocutory decision dated Feb. 14, 2017. |
EP 10183394.5 filed Apr. 25, 2006 Opponents Arguments in Support of the Appeal dated Jun. 30, 2017. |
EP 10183394.5 filed Apr. 25, 2006 Opposition by Smiths Medical ASD, Inc. dated Apr. 25, 2014. |
EP 10183394.5 filed Apr. 25, 2006 Opposition by Smiths Medical ASD, Inc. dated Dec. 2, 2015. |
EP 10183394.5 filed Apr. 25, 2006 Opposition Grounds of Appeal dated May 17, 2017. |
EP 10183394.5 filed Apr. 25, 2006 Response to Grounds of Appeal dated Nov. 3, 2017. |
EP 10183398.6 filed Apr. 25, 2006 European Search Report dated May 22, 2013. |
EP 10762377.9 filed Oct. 5, 2011 European Search Report dated Aug. 3, 2012. |
EP 10762377.9 filed Oct. 5, 2011 Office Action dated Jul. 17, 2013. |
EP 11784194.0 filed Nov. 29, 2012 Examination report dated Jul. 5, 2016. |
EP 11784194.0 filed Nov. 29, 2012 extended European search report dated Feb. 21, 2014. |
EP 13158343.7 filed Mar. 8, 2013 Examination Report dated Feb. 4, 2014. |
EP 13158343.7 filed Mar. 8, 2013 Extended European Search Report dated May 14, 2013. |
EP 13158343.7 filed Mar. 8, 2013 Summons to Attend Oral Proceedings dated Oct. 20, 2014. |
EP 13764254.2 filed Sep. 10, 2014 Extended European Search Report dated Feb. 19, 2016. |
EP 13764254.2 filed Sep. 10, 2014 Partial European Search Report dated Oct. 14, 2015. |
EP 13830592.5 filed Feb. 24, 2015 Extended European Search Report dated Mar. 21, 2016. |
EP 14198524.2 filed Dec. 17, 2014 Extended European Search Report dated Sep. 14, 2015. |
EP 15180174 filed Aug. 7, 2015 European Search Report dated Jan. 4, 2016. |
EP 15180174 filed Aug. 7, 2015 Office Action dated Jan. 13, 2017. |
EP 16 193 913.7 filed Oct. 14, 2016 Extended European Search Report dated Apr. 13, 2017. |
EP 16 193 913.7 filed Oct. 14, 2016 Office Action dated Feb. 13, 2018. |
EP 18155508.7 filed Oct. 5, 2011 Partial European Search Report dated Nov. 6, 2018. |
EP 99 964 086.5 filed Dec. 3, 1999 Office Action dated Dec. 15, 2005. |
EP 99 964 086.5 filed Dec. 3, 1999 Office Action dated Mar. 1, 2005. |
EP 99 964 086.5 filed Dec. 3, 1999 Office Action dated Mar. 30, 2005. |
Ethanol Lock Technique for Prevention and Treatment of Central line-Associated Bloodstream Infections (Nebraska) Aug. 13, 2011, Accessed: Jun. 29, 2013 http://www.nebraskamed.com/app_files/pdf/careers/education-programs/asp/tnmc_etohlock_final.pdf. |
Extravasation of Radiologic Contrast, PA-PSRS Patient Safety Advisory, vol. 1 No. 3, Sep. 2004. |
Extreme Access™ Bard Access Systems, Inc. Product Brochure, 2003. |
Leslie et al., “A New Simple Power Injector,” Am J Roentgenol 128: 381-384, Mar. 1977. |
Levin et al. “Initial results of a new access device for hemodialysis” Kidney International, vol. 54, pp. 1739-1745, (1998). |
Levin et al. “New Access Device for Hemodialysis”, ASAIO Journal (1998). |
LifeSite: Instructions for Implantation & Use for the LifeSite Hemodialysis Access System, 2000. |
MedComp “PortCT Technology”, display at SIR Conference (Mar. 2006), Toronto, Canada. |
Medcomp Dialysis and Vascular Access Products (MEDCOMP) Jun. 30, 2009, Accessed Jun. 29, 2013 http://www.medcompnet.com/products/flipbook/pdf/PN2114G_Medcomp_Catalog_pdf. |
Medtronic IsoMed Technical Manual, Model 8472, (2008). |
Medtronic IsoMed® Constant-Flow Infusion System: Clinical Reference Guide for Hepatic Arterial Infusion Therapy, Revised Sep. 2000. |
Medtronic Pain Therapies, Intrathecal Drug Delivery brochure. |
MX/a/2011/004499 filed Apr. 28, 2011 First Office Action dated Jul. 25, 2013. |
MX/a/2011/004499 filed Apr. 28, 2011 Forth Office Action dated Aug. 3, 2015. |
MX/a/2011/004499 filed Apr. 28, 2011 Second Office Action dated May 25, 2014, translation dated Jul. 28, 2014. |
MX/a/2011/004499 filed Apr. 28, 2011 Third Office Action dated Jan. 21, 2015. |
MX/a/2011/010529 filed Oct. 5, 2011 Office Action dated Apr. 24, 2018. |
MX/a/2011/010529 filed Oct. 5, 2011 Office Action dated Jan. 18, 2017. |
MX/a/2011/010529 filed Oct. 5, 2011 Office Action dated May 19, 2016. |
MX/a/2011/010529 filed Oct. 5, 2011 Office Action dated Oct. 2, 2017. |
MX/a/2014/011280 filed Mar. 13, 2013, First Office Action dated May 29, 2015. |
MX/a/2014/011280 filed Mar. 13, 2013, Second Office Action dated Oct. 27, 2015. |
Navilyst Medical, Implantable Ports with PASV® Valve Technology, Product Overview,<<http://www.navilystmedical.com/Products/index.cfm/9>> last accessed Jun. 4, 2012. |
Nebraska Medical Center, Ethanol Lock Technique for Prevention and Treatment of Central Line-Associated Bloodstream Infections, Jul. 2009. |
Norfolk Medical Design Dossier/Technical File Vortex, Dec. 1997. |
Nucleus Cochlear Implant Systems; User Manual for the ESPrit and ESPrit 22 speech processor and accessories, Issue 3, Apr. 2000. |
Nucleus Cochlear Implant Systems; User Manual for the SPrint speech processor and accessories, Issue 4, Apr. 2002. |
Oct. 22, 2009 Declaration of Kelly Christian, Director of Product Development at BARD Access Systems, Inc, in support of and depicting a product on the market by Quinton Company approximately ten years prior to Oct. 22, 2009, 1 page. |
PCT/US 09/62854 filed Oct. 30, 2009 Written Opinion dated Dec. 23, 2009. |
PCT/US06/49007 filed Dec. 21, 2006 Search Report and Written Opinion dated Oct. 1, 2007. |
PCT/US2006/008022 filed Mar. 6, 2006 International Preliminary Report on Patentability dated Sep. 12, 2007. |
PCT/US2006/008022 filed Mar. 6, 2006 Search Report dated Jul. 5, 2006. |
PCT/US2006/008022 filed Mar. 6, 2006 Written Opinion dated Apr. 9, 2007. |
PCT/US2006/008022 filed Mar. 6, 2006 Written Opinion dated Jul. 5, 2006. |
PCT/US2006/015695 filed Apr. 25, 2006 Partial Search Report dated Sep. 29, 2006. |
PCT/US2006/015695 filed Apr. 25, 2006 Search Report dated Jan. 11, 2007. |
PCT/US2006/015695 filed Apr. 25, 2006 Written Opinion dated Jan. 11, 2007. |
PCT/US2006/016056 filed Apr. 27, 2006 International Preliminary Report on Patentability dated Oct. 30, 2007. |
PCT/US2006/016056 filed Apr. 27, 2006 Search Report dated Sep. 20, 2006. |
PCT/US2006/016056 filed Apr. 27, 2006 Written Opinion dated Oct. 27, 2007. |
PCT/US2006/016056 filed Apr. 27, 2006 Written Opinion dated Sep. 20, 2006. |
PCT/US2006/049007 filed Dec. 21, 2006 International Preliminary Report on Patentability dated Jul. 1, 2008. |
PCT/US2006/049007 filed Dec. 21, 2006 Written Opinion dated Oct. 1, 2007. |
PCT/US2007/006776 filed Mar. 19, 2007 International Preliminary Report on Patentability dated Jan. 2, 2009. |
PCT/US2007/006776 filed Mar. 19, 2007 International Search Report dated Dec. 18, 2007. |
PCT/US2007/006776 filed Mar. 19, 2007 Written opinion, dated Dec. 18, 2007. |
PCT/US2007/011015 dated May 7, 2007 Written Opinion dated Jun. 10, 2008. |
PCT/US2007/011015 filed May 7, 2007 International Preliminary Report on Patentability dated Sep. 23, 2008. |
PCT/US2007/011015 filed May 7, 2007 Search Report dated Jun. 10, 2008. |
PCT/US2007/011456 filed May 11, 2007 Search Report dated Aug. 28,2008. |
PCT/US2007/011456 filed May 11, 2007 Written Opinion dated Aug. 28, 2008. |
PCT/US2008/010520 dated Sep. 8, 2008 Search Report dated Feb. 24, 2009. |
STD Manufacturing, Brochure with a Hickman port, 1 page, date unknown. |
Steinbach, Barbara G. , Hardt, N. Sisson, Abbitt, Patricia L., Lanier, Linda, Caffee, H. Hollis, “Breast Implants, Common Complications, and Concurrent Breast Disease.” RadioGraphics, vol. 13, No. 1, pp. 95-118, 1993. |
Sullivan et al. “Radiopaque Markers on Mammary Implants.” American Journal of Roentgenology 153(2):428, Aug. 1989. |
Summers, “A New and Growing family of artificial implanted fluid-control devices” vol. XVI Trans. Amer. Soc. Artif. Int. Organs, 1970. |
Takeuchi, Syuhei et al., “Safety Considerations in the Power Injection of Contrast Medium via a Totally Implantable central Venous Access System,” Japan Journal of Interventional Radiology vol. 20, No. 1, pp. 27-30, Jan. 2005. |
Tilford, C. R., “Pressure and Vacuum Measurements”—Ch 2 of Physical Methods of Chemistry pp. 101-173, 1992. |
Toray “P-U Celsite Port” brochure—Sep. 1999. |
U.S. Department of Health and Human Services, FDA, “Labeling: Regulatory Requirements for Medical Devices” Aug. 1989. |
U.S. Food and Drug Administration, “Guidance for Institutional Review Boards and Clinical Investigators 1998 Update: Medical Devices.” Version Sep. 10, 2008. |
U.S. Appl. No. 60/658,518, filed Mar. 4, 2005, publicly accessible Oct. 5, 2006. |
Urquiola, Javier, et al., “Using Lead Foil as a Radiopaque Marker for Computerized Tomography Imaging When Implant Treatment Planning.” The Journal of Prosthetic Dentistry, 1997. |
U.S. Appl. No. 10/374,000, filed Febraury 25, 2003 Office Action dated Aug. 28, 2007. |
U.S. Appl. No. 10/374,000, filed Feb. 25, 2003 Advisory Action dated Jan. 23, 2007. |
U.S. Appl. No. 10/374,000, filed Feb. 25, 2003 Non-Final Office Action dated Feb. 13, 2006. |
U.S. Appl. No. 10/374,000, filed Feb. 25, 2003 Non-Final Office Action dated May 20, 2009. |
U.S. Appl. No. 10/374,000, filed Feb. 25, 2003 Non-final Office Action dated Mar. 20, 2008. |
U.S. Appl. No. 10/374,000, filed Feb. 25, 2003 Office Action dated Feb. 28, 2007. |
U.S. Appl. No. 10/374,000, filed Feb. 25, 2003 Office Action dated Jul. 28, 2006. |
U.S. Appl. No. 10/374,000, filed Feb. 25, 2003 Office Action dated Sep. 30, 2008. |
U.S. Appl. No. 10/374,000, filed Feb. 25, 2003 Response to Non-Final Office Action dated May 12, 2006. |
U.S. Appl. No. 10/374,000, filed Feb. 25, 2003 Response to Office Action dated Dec. 28, 2006. |
U.S. Appl. No. 10/374,000, filed Feb. 25, 2003 Response to Office Action dated Jun. 20, 2008. |
U.S. Appl. No. 10/374,000, filed Feb. 25, 2003 Response to Office Action dated Mar. 30, 2009. |
U.S. Appl. No. 10/374,000, filed Feb. 25, 2003 Response to Office Action dated May 28, 2007. |
U.S. Appl. No. 10/374,000, filed Feb. 25, 2003 Response to Office Action dated Nov. 28, 2006. |
U.S. Appl. No. 10/374,000, filed Feb. 25, 2003 Response to Office Action dated Oct. 31, 2007. |
U.S. Appl. No. 10/374,000, filed Feb. 25, 2003 Response to Office Action dated Sep. 21, 2009. |
U.S. Appl. No. 11/320,223, filed Dec. 28, 2005 Advisory Action dated Dec. 1, 2011. |
U.S. Appl. No. 11/320,223, filed Dec. 28, 2005 Notice of Allowance dated Jan. 6, 2012. |
U.S. Appl. No. 11/320,223, filed Dec. 28, 2005 Final Office Action dated Aug. 3, 2011. |
U.S. Appl. No. 11/320,223, filed Dec. 28, 2005 Final Office Action dated Jun. 19, 2009. |
U.S. Appl. No. 11/320,223, filed Dec. 28, 2005 Final Office Action dated Jun. 22, 2010. |
U.S. Appl. No. 11/320,223, filed Dec. 28, 2005 Non-Final Office Action dated Feb. 13, 2008. |
U.S. Appl. No. 11/320,223, filed Dec. 28, 2005 Non-Final Office Action dated Jan. 21, 2010. |
U.S. Appl. No. 11/320,223, filed Dec. 28, 2005 Non-Final Office Action dated Mar. 16, 2011. |
U.S. Appl. No. 11/320,223, filed Dec. 28, 2005 Non-Final Office Action dated Sep. 18, 2008. |
U.S. Appl. No. 11/368,954, filed Mar. 6, 2006 Non-Final Office Action dated Jul. 21, 2009. |
U.S. Appl. No. 11/368,954, filed Mar. 6, 2006 Notice of Allowance dated Jun. 24, 2010. |
U.S. Appl. No. 11/368,954, filed Mar. 6, 2006 Final Office Action dated Jan. 27, 2010. |
U.S. Appl. No. 11/368,954, filed Mar. 6, 2006 Supplemental Non-final Office Action dated Oct. 2, 2009. |
U.S. Appl. No. 11/380,124, filed Apr. 25, 2006 Final Office Action dated Aug. 13, 2010. |
U.S. Appl. No. 11/380,124, filed Apr. 25, 2006 Final Office Action dated Oct. 20, 2011. |
U.S. Appl. No. 11/380,124, filed Apr. 25, 2006 Final Office Action dated Sep. 21, 2009. |
U.S. Appl. No. 11/380,124, filed Apr. 25, 2006 Non-Final Office Action dated Apr. 26, 2010. |
U.S. Appl. No. 11/380,124, filed Apr. 25, 2006 Non-Final Office Action dated Apr. 7, 2011. |
U.S. Appl. No. 11/380,124, filed Apr. 25, 2006 Non-Final Office Action dated Jan. 16, 2009. |
U.S. Appl. No. 11/380,124, filed Apr. 25, 2006 Non-Final Office Action dated Oct. 28, 2010. |
U.S. Appl. No. 11/380,124, filed Apr. 25, 2006 Notice of Allowance dated Apr. 29, 2013. |
U.S. Appl. No. 11/380,621, filed Apr. 27, 2006 Final Office Action dated Jan. 14, 2010. |
U.S. Appl. No. 11/380,621, filed Apr. 27, 2006 Final Office Action dated Jan. 23, 2009. |
C.R. Bard, Inc. “Hickman Subcutaneous Ports & Hickman /Broviac Catheters Brochure” Brochure, 1992. |
CA 2757836 filed Oct. 5, 2011 Examiner's Report dated May 18, 2016. |
Canaud et al. “Dialock: a new vascular access device for extracorporeal renal replacement therapy. Preliminary clinical results” Nephrol. Dial. Transplant 14: 692-698 (1999). |
Canaud et al. “Dialock: Pilot Trial of a New Vascular Port Access Device for Hemodialysis” Seminars in Dialysis, vol. 12, No. 5, pp. 382-388 (Sep. 1999). |
Canaud et al. “Dialock: Results of french multicentar trial” Nephrology, vol. 22, No. 8, pp. 391-397, (2001). |
Cardiovascular and Interventional Radiology, Review Article, “Central Venous Access Catheters: Radiological Management of Complications,” by U.K. Teichgraber, B. Gebauer, T. Benter, H.J. Wagner, published online Jul. 31, 2003. |
Carlson et al., “Safety Considerations in the Power Injection of Contrast Media Via Central Venous Catheters during Computed Tomographic Examinations,” Investigative Radiology, (May 1992) 27: 337-340. |
Carlson, J. E. et. al., “Safety Considerations in the Power Injection of Contrast Media Via Central Venous Catheters during Computed Tomographic Examinations” Investigative Radiology, vol. 27, p. 337-340, May 1992. |
Center for Devices and Radiological Health, Guidance on 510(k) Submissions for Implanted Infusion Ports, Oct. 1990. |
Clinical Plastic Products, “Oncology Jet Port Plus Catheter Systems” Instructions for Use, Oct. 12, 2011. |
CN 200980153471.3 filed Jun. 30, 2011 Fifth Office Action dated Jun. 2, 2015. |
CN 200980153471.3 filed Jun. 30, 2011 First Office Action dated Dec. 25, 2012. |
CN 200980153471.3 filed Jun. 30, 2011 Fourth Office Action dated Nov. 15, 2014. |
CN 200980153471.3 filed Jun. 30, 2011 Notice of Grant dated Nov. 5, 2015. |
CN 200980153471.3 filed Jun. 30, 2011 Second Office Action dated Sep. 18, 2013. |
CN 200980153471.3 filed Jun. 30, 2011 Third Office Action dated May 28, 2014. |
CN 201080020088.3 filed Nov. 7, 2011 First Office Action dated Mar. 4, 2013. |
CN 201080020088.3 filed Nov. 7, 2011 Second Office Action dated Nov. 21, 2013. |
CN 201080051911.7 filed May 16, 2012 First Office Action dated Dec. 27, 2013. |
CN 201080051911.7 filed May 16, 2012 Second Office Action dated Jul. 16, 2014. |
CN 201080051911.7 filed May 16, 2012 Third Office Action dated Jan. 30, 2015. |
CN 201380016157.7 filed Sep. 23, 2014 First office action dated May 16, 2016. |
CN 201380016157.7 filed Sep. 23, 2014 Office Action dated Feb. 4, 2017. |
CN 201380016157.7 filed Sep. 23, 2014 Office Action dated Jun. 1, 2017. |
CN 201410216386.X filed May 21, 2014 First Office Action dated Nov. 2, 2015. |
CN 201410216386.X filed May 21, 2014 Office Action dated Jun. 24, 2016. |
CN 201410216386.X filed May 21, 2014 Office Action dated Nov. 29, 2016. |
CN 201410216386.X filed May 21, 2014 Search Report dated Nov. 2, 2015. |
CN 201510645219.1 filed Nov. 1, 2015 Office Action dated Nov. 16, 2017. |
CN 201610037718.7 filed Jan. 20, 2016 Office Action dated Jul. 2, 2018. |
CO 14.235.202 filed Oct. 23, 2014 Office Action dated Apr. 25, 2017. |
CO 14.235.202 filed Oct. 23, 2014 Office Action dated Nov. 3, 2016. |
CO 14.235.202 filed Oct. 23, 2014 Office Action dated Oct. 3, 2017. |
Cook Vital-Port® Product Catalog (2000). |
Costa, Nancy, “More Than Skin Deep: An Overview of Iodinated Contrast Media..” Journal for the Association for Vascular Access, vol. 8, No. 4, 2003. |
Costa, Nancy, “Understanding Contrast Media.” Journal of Infusion Nursing, vol. 27, No. 5, Sep./Oct. 2004. |
Council Directive 93/42/EEC of Jun. 14, 1993 concerning medical devices (Jun. 14, 1993). |
Coyle, Douglas et al, Power Injection of Contrast Media via Peripherally Inserted Central Catheters for CT, J Vasc Intery Radiol, pp. 809-814, vol. 15, 2004. |
Declaration by Hank LaForce U.S. Pat. No. 7,785,302 (Ref D13 of Request for Trial for Invalidation dated May 22, 2017). |
Defendant's Amended Answer to Plaintiffs' First Amended Complaint and Amended Counterclaims dated Sep. 2017. |
Deltec Port Systems (Feb. and Apr. 1996). |
Department of Health and Human Services, C-Port 510(k) FDA Clearance, Jun. 5, 2003. |
Department of Health and Human Services, PowerPort 510(k) FDA Clearance, Jan. 25, 2007. |
Desmeules et al. “Venous Access for Chronic Hemodialysis: ‘Undesirable Yet Unavoidable’”, Artificial Organs 28 (7):611-616 (2004). |
Documents attached to P-U Celsite Port (new model first edition to sixth edition) (Ref D10 of Request for Trial for Invalidation dated May 22, 2017). |
ECRI Institute, Healthcare Product Comparison System, Dec. 2007. |
EP 06 751 411.7 filed Apr. 25, 2006 Office Action dated Sep. 2, 2008. |
EP 06737222.7 filed Aug. 17, 2007 Office Action dated Jul. 27, 2016. |
EP 06737222.7 filed Aug. 17, 2007 Office Action dated Mar. 9, 2017. |
EP 06751411 filed Apr. 25, 2006 Decision of the Technical Board of Appeal dated Jul. 24, 2013. |
Number | Date | Country | |
---|---|---|---|
20190134373 A1 | May 2019 | US |
Number | Date | Country | |
---|---|---|---|
60658518 | Mar 2005 | US | |
61110507 | Oct 2008 | US |
Number | Date | Country | |
---|---|---|---|
Parent | 14599376 | Jan 2015 | US |
Child | 15881616 | US | |
Parent | 13776517 | Feb 2013 | US |
Child | 14599376 | US | |
Parent | 13250909 | Sep 2011 | US |
Child | 13776517 | US | |
Parent | 12796133 | Jun 2010 | US |
Child | 13250909 | US |
Number | Date | Country | |
---|---|---|---|
Parent | 15881616 | Jan 2018 | US |
Child | 16241775 | US |
Number | Date | Country | |
---|---|---|---|
Parent | 12610084 | Oct 2009 | US |
Child | 12796133 | US | |
Parent | 12420028 | Apr 2009 | US |
Child | 12610084 | US | |
Parent | 11368954 | Mar 2006 | US |
Child | 12420028 | US |